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Abstract: 
 Introduction: Periradicular periodontitis is an inflammatory disease caused by 
perpetual microbial infection in the root canal system which, if left untreated, results in 
the destruction of tooth supporting tissues. Tenacious infection of virulent bacteria can 
lead to continuous activation of host immune response which results in excess 
production of proinflammatory mediators, including the bone resorption factor RANKL. 
To date, attempts to minimize the destruction of tooth supporting tissues have included 
laser therapy and phototherapy, but these approaches have been confined to treating 
and monitoring the exogenous etiology, i.e., bacterial infection. Therefore, to improve 
the diagnosis and treatment of periradicular periodontitis, new technologies are needed 
to control host cell biological responses and evaluate the level of inflammation in the 
root canal system and periradicular area. 
  
 Objectives: Intracellular generated adenosine triphosphate (ATP) and its 
metabolite, adenosine (ADO), act as major energy currencies in the cell system. Only 
recently has it been reported that extracellular ATP (eATP) released from activated 
neutrophils elicits proinflammatory responses, while ADO, which is generated via 
enzymatic conversion of ATP by cell surface-expressed ecto-5!-nucleotidase (CD73) 
and Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase1/CD39), functions 
as anti-inflammatory mediator. Accordingly, this study investigated the effects of CD73 
and ADO on osteoimmunological bone resorption in periradicular periodontitis. 
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 Methods: The possible anti-bone loss role of ADO was examined in vitro by 
reacting RANKL-stimulated RAW264.7 osteoclast precursors with ADO receptor agonist 
5!-(N-Ethylcarboxamido) adenosine (NECA). More specifically, the effects of NECA on 
RANKL-induced osteoclastogenesis were evaluated by monitoring TRAP+ 
multinucleated cell number and pit formation. Since activated T cells are the major 
cellular source of RANKL in periradicular periodontitis, the effects of NECA on 
proliferation and sRANKL production by TCR/CD28-stimulated T cells were examined in 
vitro. The therapeutic efficacy of NECA on the pathogenic bone loss induced in 
periradicular periodontitis was evaluated in a pulp exposure-induced periradicular 
periodontitis model using C57BL/6 wild-type (WT) mice. On the other hand, the impact 
of ADO loss-of-function was compared between CD73-/-Foxp3-GFP+/+ mice and WT 
mice, both with experimentally induced periradicular lesion. Periradicular tissues were 
isolated from sacrificed mice, and the mRNAs of inflammation-associated and bone 
remodeling-related genes, amount of ATP and size of periradicular lesions were 
monitored up to 3 weeks using qPCR and "CT. Expressions of CD73 and other proteins 
in the periradicular tissues were examined by immunohistochemistry and 
immunofluorescence staining. 
  
 Results: As determined from the in vitro experiments, NECA significantly 
suppressed not only RANKL-mediated osteoclastogenesis from RAW264.7 cells 
(P<0.05), but also significantly downregulated proliferation and RANKL production from 
TCR/CD28-activated T cells (P<0.05), suggesting that the elicited signal could 
downregulate RANKL-induced osteoclastogenesis. As determined from the in vivo 
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experiments, the amount of ATP and expression of CD73 mRNA were significantly 
increased in the mouse periradicular lesion in a time-dependent manner. NECA-treated 
wild-type (WT) mice demonstrated significantly elevated mRNAs for CD39, CD73, 
alkaline phosphatase, and RUNX2, while showing decreased expressions of  RANKL 
and IL1-# mRNAs, accompanied by diminished size of periradicular lesion, compared to 
nondrug-treated control WT mice experimentally induced with periradicular lesion. 
Finally, the amount of ATP and mRNAs for RANKL, IL1-#, IL-6, and TNF-$, as well as 
the size of periradicular lesion, were significantly larger (P<0.05) in CD73-/-Foxp3-
GFP+/+ compared to control WT-mice. 
  
 Conclusion: By its catalytic action to convert ATP to ADO, increased CD73, by 
its catalytic action to convert ATP to ADO, in the periradicular lesion may play a role in 
downregulating inflammatory bone loss, suggesting the CD73/ADO axis as a novel 
therapeutic target for periradicular periodontitis, leading to the development of a 
therapeutic regime which, beyond controlling bacterial infection, can control host cell 
biological responses and, hence, the level of inflammation in the affected root apex. 
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Introduction 
 Periradicular periodontitis is an inflammatory disease that is caused by perpetual 
microbial infection in the root canal system, and it is usually followed by the destruction 
of the tooth supporting tissues, which include alveolar bone and periodontal ligament 
tissue. Failure of host response to eliminate virulent bacteria can lead to the over-
activation of the host immune response resulting in excess production of 
proinflammatory mediators. In particular, RANKL produced by activated lymphocytes is 
the key cytokine that can induce bone loss in periradicular periodontitis by activation of 
osteoclasts. To date, several approaches have attempted to control host response and 
minimize destruction in the supporting tissues; however, such therapeutic approaches 
have been solely confined to treating the etiology, i.e., endodontic pathogens, in the root 
canal system. For the diagnosis and prognosis of periradicular periodontitis, a test to 
monitor the root canal infection of bacteria is practically employed.  However, no 
methods have been developed to monitor biological responses, especially the level of 
inflammation, occurring in the periradicular lesion. In order to provide better diagnosis 
and prognosis of periradicular periodontitis, development of a non-biased monitoring 
system that reflects inflammatory status is sought.  
 ATP and its breakdown product adenosine (ADO) have been very well studied 
for their intracellular roles as the “energy currency” of cells. It is only very recently that 
these molecules have been recognized for their extracellular roles in regulating 
inflammatory processes. For example, extracellular ATP released from injured cells, or 
activated neutrophils, is causal for proinflammatory responses. More specifically, ATP 
released from activated neutrophils elicits a major endogenous danger signal via 
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ligation to the purinergic receptors, leading to the production of proinflammatory 
cytokines from surrounding leukocytes, such as T cells and macrophages that express 
P2X and P2Y receptors.  
 On the other hand, it was also revealed that eATP could be hydrolyzed to 
adenosine (ADO) by the ectonucleotidases CD39 and CD73, which are expressed on 
the surface of cells, including endothelial cells and lymphocytes. While eATP elicits 
proinflammatory responses, extracellular ADO (eADO) functions as an anti-
inflammatory mediator, a key idea fundamental to the hypothesis supporting this 
proposal. It is known that ADO receptors, which have 4 isoforms, including A1, A2A, A2B 
and A3, are expressed in various organs and tissues. T cells express A2A and A2B 
receptors, which elicit inhibitory signals in activated effector T cells. Furthermore, 
chemical agonists for ADO receptors have been developed. Selective ligands of A1, 
A2A, A2B and A3 ADO receptors have shown potential in the treatment of numerous 
disorders in which inflammation is a feature.  
 In terms of the effects of extracellular purine nucleosides on osteoclast-mediated 
bone loss, ligation of P2Y nucleotide receptors appears to activate osteoclasts through 
NF-kB signaling, while agonists for adenosine receptors were reported to inhibit 
RANKL-mediated osteoclastogenesis. However, few studies have reported on the 
effects of extracellular adenosine on periradicular periodontitis. Since neutrophils are 
the major cellular infiltrates, following lymphocytes, in the periradicular lesion, it is 
conceivable that eATP levels increase in the periradicular tissues during the initial 
phase of immune-inflammatory response. However, as the disease state of periradicular 
lesion progresses, it has also been reported that the number of Foxp3+ Treg cells 
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increases in the periradicular lesion induced in a mouse model, suggesting that Foxp3+ 
Treg cells may participate in anti-inflammatory and anti-bone loss responses by 
conversion of ATP to ADO using CD73 expressed on their cell surface. In sum, this 
evidence suggests that the biological process of eATP may promote periradicular bone 
resorption, while elevation of the ADO concentration in local inflammatory lesion may 
suppress it. Thus, it would be worth investigating if eADO affects the production of 
RANKL by activated T cells or if eADO modulates RANKL-mediated 
osteoclastogenesis. 
 Therefore, the goals of this study are to 1) test the feasibility of ATP and ADO as 
biomarkers that reflect the status of proinflammatory and anti-inflammatory host 
responses in the periradicular lesion, respectively, and 2) examine if the approach to 
increase eADO can suppress the bone resorption induced in periradicular lesion. 
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Review of the literature: 
Periradicular periodontitis: 
 Periradicular periodontitis is an inflammatory disease that is caused by persistent 
microbial infection in the root canal system, followed by the destruction of the tooth 
supporting tissues [1-3]. To reach the pulp and infect the root canal system, bacteria in 
the oral cavity have to pass through the dental hard structure. This can be achieved by 
caries, trauma, cracks, and rarely through lateral and apical foramina [4, 5]. 
Periradicular periodontitis occurs as a result of local inflammatory response, which is 
mediated by infiltrated inflammatory cells and their products [6, 7]. The inflammatory 
process ultimately results in periradicular bone resorption, which is the unique function 
of osteoclasts [8, 9]. Periradicular periodontitis is an outcome to endodontic infection 
and demonstrate itself as host defense response to pathogens emerging from the root 
canal system. It is viewed as a vigorous confronts between pathogenic factors and host 
defenses at periradicular area that result in local inflammatory response and resorption 
of periradicular tissues [10]. However, Once the root canal system has been properly 
cleaned and disinfected, Healing of the periradicular lesion and formation of new bone 
supporting tissue can begin [11]. Accordingly, Understanding the mechanisms of bone 
resorption and formation is crucial to the development of therapies for bone destructive 
diseases including periradicular periodontitis. 
 To date, several approaches have attempted to control host response and 
minimize destruction in the supporting tissues; however, such therapeutic approaches 
have been solely confined to treating the etiology, i.e., endodontic treatment. 
Meanwhile, no methods have been developed to monitor biological responses, 
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especially the level of inflammation, occurring in the periradicular lesion. In order to 
provide better diagnosis and prognosis of periradicular periodontitis, it would be 
desirable to develop a non-biased monitoring system that reflects inflammatory status in 
the pulp. 
Periradicular immune response: 
 When the root canal system gets infected, various innate and adaptive immune 
cells release high amounts of inflammatory mediators. Basically, the innate immune 
response in the periradicular area can be manifested by the production of inflammatory 
cytokines and inflow of phagocytic leukocytes, most prominently polymorphonuclear 
leukocytes (PMNs) which play an important role as the first line of defense in 
periradicular periodontitis. Moreover, several studies showed that periradicular lesions 
composed of numerous and multiple types of inflammatory cells. These cells include T 
lymphocytes, B lymphocytes, macrophages, PMNs, plasma cells, mast cells, natural 
killer (NK), and dendritic cells [12-16]. Periradicular response can be considered as a 
duty of the immune system to confine and localize infections to prevent systemic 
dissemination [9, 17]. The innate immunity response to bacteria will influence and 
motivate the release of proinflammatory cytokines which is crucial for activation of 
adaptive immune response [18]. T- and B-cell-mediated adaptive immune responses 
will then act as protection from endodontic microbes, as well as develop bacterium-
specific antibodies [7]. 
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RANKL as possible mechanism of bone resorption process in periradicular 
periodontitis: 
 Receptor activator of NF-%B ligand (RANKL), osteoprotegerin (OPG) ligand 
(OPGL), and TNF-related activation-induced cytokine (TRANCE), are the most potent 
factors for inducing osteoclastogenesis [19, 20]. Prior to this discovery in the mid-1990s, 
consensus held that osteoclast development was regulated by factors expressed by 
“osteoblast/stromal cells”, but no expectation was made that members of the TNF 
superfamily would be involved in bone remodeling [21]. RANKL is a member of the TNF 
cytokine family, and both membrane-bound (mRANKL) and soluble receptor activator of 
NF-kappaB ligand (sRANKL) are expressed in human T-cells, while the functional 
differences between the two remain unclear [22] The natural decoy receptor for RANKL 
is OPG, and osteoclast formation is regulated by the balance between OPG and 
RANKL [23]. The expression level of RANKL mRNA in human periradicular lesion is 
significantly higher than that of healthy periradicular tissue [24, 25], suggesting that 
locally produced RANKL is responsible for periradicular bone resorption.  Nevertheless, 
the biological mechanism underlying such increase of RANKL in the periradicular lesion 
with attendant pathogenic bone resorption remains unclear. Therefore, investigating the 
pathophysiological mechanism causing periradicular lesions can lead the discovery of 
new novel therapies for periradicular periodontitis. 
Tregs and its functions: 
Tregs were formerly called suppressor T cells and were first reported in the early 
1970s [26] and thought to be a special CD8+ subset. However, the old thought about 
this cell population was changed describing it as a minor population of CD4+ T cells 
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[27]. Subsequently, studies revealed that CD4+CD25+ T cells can suppress other cells 
and hypo-responsive at the same time [28]. Treg can inhibit T cell response and prevent 
disease in many animal models [29] suppress both adaptive and innate immune 
response [30-32]. Other studies showed that CD4+CD25+ Treg cells could suppress the 
proliferation of CD8+ and CD4+ T cells by its action independently of TGF-# and IL-10 
cytokines. This was proven using Tregs derived from TGF-# and IL-10 deficient mice 
[29]. 
RANKL produced by T cells may be responsible for the osteoclast-mediated 
periradicular bone resorption: 
Recent study using a mouse model of periradicular periodontitis demonstrated 
that CD3+ T lymphocytes produce RANKL in response to the bacteria infecting in the 
exposed dental pulp, which, in turn, results in the periradicular bone resorption [33]. 
More specifically, RANKL-positive T-cells, along with TARP+ osteoclasts, were 
identified in periradicular lesions induced in mice by pulp exposure. The commensal 
bacterium in mouse oral cavity, Pasteurella Pneumotropica (P. pnumotropica(Pp)), 
which was most often detected from inflamed exposed pulp, showed notably elevated 
serum IgG antibody response in pulp-exposed mice compared to control non-treated 
mice, indicating that the adaptive immune response is induced against P. pnumotropica 
after the pulp exposure. Very importantly, Pp-reactive T-cells isolated from Pp-
immunized mice produced sRANKL in response to ex vivo exposure to P. 
pneumotropica. Therefore, as a result of adaptive immune response induced against 
bacteria infecting dental pulp, these results suggested that activated bacteria-reactive T 
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cells might cause periradicular bone resorption in a mouse model of periradicular 
periodontitis 
In contrast to effector T cell subsets, such as, Th1, Th2 or Th17 cells, which 
mediate inflammatory responses, CD25+Foxp3+ regulatory T-cells (Treg) play a pivotal 
role in downregulating the overactivation of Th1, Th2 or Th17 cells. In the context of 
marginal periodontitis, the incidence of CD4+CD25+ Treg cells increase along with 
elevated levels of B-cells relative to T-cells, compared to healthy control gingival tissue 
or gingivitis tissue. Expressions of Foxp3+ (forkhead box P3), the key transcription 
factor controlling regulatory T-cells, anti-inflammatory cytokines, including TGF-#1, and 
IL-10, are more prominent in periodontitis than gingivitis or healthy control [34-36]. It 
was also reported that that CD4+CD25+Foxp3+ Treg cells increased in periradicular 
lesions of human patients and that these Treg cells expressed IL-10 and TGF-#. Human 
Treg cells are also reported to suppress the proliferation of effector T-cells in vitro, in part 
by stimulating the production of IL-10 [37, 38]. These reports suggest that Treg cells in 
both marginal and periradicular periodontitis may play regulatory roles in controlling 
local immune/inflammatory processes. 
In the mouse model of periradicular periodontitis, the infiltration of Foxp3+ Treg 
cells in the bone resorption lesion also increases [39]. Interestingly, Treg infiltration into 
mouse periradicular lesion is delayed (days 7 to 14) compared to the infiltration of other 
effector immune cells, indicating that Treg cells infiltrate as a counter-regulatory 
mechanism to attenuate overactive inflammatory response. These lines of evidence 
lead to the hypothesis that Treg could help control the expansion of periradicular lesion, 
but such premise remains to be proven. 
 
 
18 
 
CD73 (Cluster of Differentiation 73): 
 CD 73 is a membrane-bound glycoprotein (ectoenzyme) expressed on many cell 
types including endothelial cells, subsets of T and B lymphocytes (mainly Tregs), and 
mesenchymal cells. This ectoenzyme is encoded by the NT5E gene in humans and 
Nt5e gene in mice. CD73 can hydrolyze Adenosine monophosphate (AMP) into 
adenosine. This adenosine can activate transmembrane ADO receptors and can 
function as either an anti-inflammatory or proinflammatory mediator. ADO also regulates 
permeability of the blood vessels endothelium and other hematological activities after an 
inflammatory stimulus. 
CD73KO mice: 
 This knockout mouse was developed in 2004 by Linda F. Thompson, Oklahoma 
Medical Research Foundation, by targeting and replacing exon 3 of the 5' ecto-
nucleotidase (Nt5e) gene at chromosome 9, thus eliminating the fraction of this 
ectoenzyme. These mice breed and gained weight normally, and they also have an 
intact immune system [40]. They exhibited increased edema in all organs except the 
brain, and increased vascular leakage under hypoxia. These KO mice show increased 
aggression toward humans as a behavioral phenotypic change. They can be used in the 
study of inflammatory and autoimmune diseases, as well as cancer and cardiovascular 
disorders. 
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The function of CD73 and CD39 in the immune system: 
 Recently, CD73 and CD39 have been further used as Tregs marker due to their 
high expression on the surface of Foxp3+ Tregs [41, 42]. Given the importance of both 
CD73 and CD39 in dephosphorylating the ATP to ADO and altering the ATP mediated 
proinflammatory status toward ADO-driven anti-inflammatory effects, they can both be 
viewed as “immunological switches” [43]. Also, a recent study showed that CD73 
produced by Tregs downregulated the production of NF-%B through adenosine receptor 
A2A and reduced the production of proinflammatory mediators [44].  
 With particular respect to innate immunity, elevation eATP levels can lead to 
activation of neutrophils, while elevated levels of eADO will lead to high production of 
anti-inflammatory mediators to prevent potential tissue injury [45]. Since neutrophils 
express both CD39 and CD73, These ectoenzymes are crucial in regulating and 
controlling extracellular purinergic activity to prevent inflammatory tissue injury caused 
by prolonged inflammatory response [46-48]. Moreover, macrophage activation and 
induction of proinflammatory cytokines such as IL-1#, IL-6, IL-18, and TNF-$ are 
regulated by extracellular purine concentrations which are, in turn, regulated by 
CD39/CD73 axis [49-51]. A recent study showed that proinflammatory M1 macrophages 
reduced the amount of CD73 and CD39 which led to ATP accumulation and higher 
inflammatory response. On the contrary, M2 anti-inflammatory macrophages elevated 
the amount of CD73 and CD39, eventually increasing ADO levels leading to diminishing 
inflammatory response [52, 53]. 
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Extracellular Adenosine and its four receptors: 
 Adenosine is formed from its precursor, adenosine triphosphate (ATP), in both 
intracellular and extracellular spaces. Adenosine triphosphate (ATP) and its breakdown 
product adenosine are very well studied in their intracellular roles as the “energy 
currency” of cells. It is only recently that these molecules have been recognized in their 
extracellular roles in regulating inflammatory processes. Metabolically stressful 
condition, such as hypoxia, ischemia and inflammation, can dramatically increase the 
extracellular purine nucleosides: ATP, ADP and adenosine [54]. It is well known that 
eATP can be hydrolyzed to adenosine (ADO) by ectonucleotidases CD39 (ENTPD1 
[ectonucleoside triphosphate diphosphohydrolase-1]) and CD73 [55]. Diverse effects of 
extracellular purine nucleosides upon physiological process have now been 
characterized, including immune and inflammatory functions as discussed before. 
 Extracellular adenosine triphosphate (eATP) released from injured cells or 
activated neutrophils is causal for pro-inflammatory responses [56]. More specifically, 
ATP released from activated neutrophils elicits a major endogenous danger signal via 
ligation to the purinergic receptors P2X and P2Y, leading to the production of pro-
inflammatory cytokines from surrounding leukocytes, such as T-cells and macrophages 
that express these receptors.  
 On the other hand, eADO binds to four different cell surface ADO receptors: A1, 
A2A, A2B, and A3. It is known that ADO receptors are expressed in various organs and 
tissues. T-cells express A2A and A2B receptors, which elicit inhibitory signals in the 
effector T cells [57]. Furthermore, chemical agonists for ADO receptors have been 
developed. Accordingly, selective ligands of A1, A2A, A2B, and A3 ADO receptors are 
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likely to be potent in the treatment of pain, arthritis, cancer and other disorders in which 
inflammation is a feature [58]. 
 In terms of effects of extracellular purine nucleosides on osteoclast-mediated 
bone loss, ligation of P2Y nucleotide receptors (P2Y6 and P2Y7) appears to activate 
osteoclasts through NF-kB signaling [59, 60], while agonists for adenosine receptors 
were reported to inhibit RANKL-mediated osteoclastogenesis [61]. However, few 
studies in the literature have reported on the effects of eATP and eADO on periradicular 
periodontitis. Since neutrophils are the major cellular infiltrates following lymphocytes in 
the periradicular lesion [62], it is conceivable that the level of eATP increases in the 
periradicular tissue. However, the amount of ATP as well as ADO in the context of 
periradicular lesion has never been studied. In sum, these lines of evidence implicate a 
biological process in which eATP may promote periradicular bone resorption, while, at 
the same time, an elevated concentration of ADO in local inflammatory lesion may 
suppress it. 
Extracellular Adenosine produced by Treg cells may suppress periradicular 
periodontitis. 
 While production of anti-inflammatory cytokines, such as TGF-# and IL-10, from 
Treg cells are implicated in the immunosuppressive mechanism mediated by Treg cells, it 
remains unclear whether factors produced by Treg cells can inhibit the inflammatory 
bone resorption in the periradicular lesion. Importantly, Tregs have been reported to 
induce tolerance in effectors T cells by eADO production based on their distinct 
expression of CD73 which converts eATP to adenosine [63, 64]. Indeed, considering 
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Treg mediated immunosuppression, it appears that IL-10 production from Treg cells 
seems to be required for ADO production, and that deficiency of ADO production from 
Treg cells isolated from IL-10 KO mice results in the failure to inhibit contact 
hypersensitivity reaction [65]. Interestingly, it is totally unknown whether eADO affects 
the production of sRANKL by activated T-cells or if eADO modulates RANKL-mediated 
osteoclastogenesis. Collectively, therefore it is hypothesized that eADO produced by 
Treg cells may play a role in the suppression of RANKL production in periradicular 
periodontitis 
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Specific Aims: 
 The interaction between pathogenic bacteria and local host immune response in 
the periradicular tissue with periradicular periodontitis leads to leukocyte infiltration 
composed of lymphocytes and neutrophils which, in turn, cause apical bone resorption 
and surrounding tissue destruction, partly by the production of proinflammatory 
cytokines RANKL. Recent study using a mouse model of periradicular periodontitis 
demonstrated that infiltration of Foxp3+ T regulatory (Treg) cells in the periradicular 
lesion increases during the late stage of this disease, suggesting that Treg cells 
downregulates’ overreaction to the endodontic pathogens of which production of 
RANKL leads to the osteoclast-dependent bone loss in the periradicular lesion. 
However, it is unknown if 1) ATP produced from neutrophils in periradicular lesion can 
function as a proinflammatory mediator and 2) ADO converted from ATP by CD73 
expressed on Treg cells can, in turn, attenuate inflammatory bone resorption. Current 
therapeutic modalities treat the etiology of periradicular lesion, i.e., bacteria infiltrating 
the root canal system. In contrast, therapies that can directly affect host immune 
response are presently absent. 
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Hypothesis 
It is hypothesized that eADO produced by CD73+Foxp3+ Treg cells may play a role in 
suppressing the bone resorption induced in periradicular periodontitis. 
 
This hypothesis was tested in the following three aims: 
 
Specific Aim 1: 
To investigate the effects of eADO produced from Foxp3+ T regulatory (Treg) cells on 
the suppression of bone resorption induced in the course of periradicular periodontitis. 
 
Specific Aim 2: 
To determine if extracellular ADO produced by CD73+Foxp3+ Treg cells can suppress 
RANKL production from TCR/CD28-stimulated T cells, which, in turn, down-regulate 
periradicular bone resorption. 
 
Specific Aim 3: 
To find an approach to increase eADO by administration of ADO receptor agonist as a 
possible adjunct to non-surgical root canal therapy. 
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Materials and methods: 
 All the materials, methods, and protocols used in this study were previously 
optimized in our lab or used according to the respective manufacturer’s instructions. 
In-vitro methods: 
RANKL Mediated Osteoclastogenesis Assays: 
 Cells (RAW 264.7 cell line) were seeded in a 96 well plates (3000 cells/well) for 
TRAP staining assay and Corning® Osteo Assay Surface 24 well plates (Corning Life 
Sciences, catalog no. 3988XX1) (5000 cells/well) for pit formation assay. Minimum 
Essential Medium (MEM) Alpha (MEM$ - Gibco) was used as a culture medium. The 
medium was supplemented with 10% FBS, 0.1 mM NEAA, 100 IU/ml penicillin and 100 
µg/ml streptomycin. The plates were incubated in optimal conditions (37°C and 5% 
CO2) for 24 hours. Cells were treated with different concentrations of ADO receptor 
agonists: NECA (potent non-selective adenosine receptor agonist with high affinity to 
A2B), IB-MECA (Potent and selective A3 adenosine receptor agonist), and CCPA 
(Potent and selective adenosine A1 receptor agonist) ranging from 1 to 1000ng/ml in 
the presence of rRANKL 50 ng/ml (Propretech®). The media was replenished every 72 
hours. After 6 days, when multinucleated osteoclast-like cells were observed, the cells 
were used for TRAP staining. 
a. Tartrate Resistant Acid Phosphatase (TRAP) staining 
 In order to measure the mature osteoclasts differentiated from RAW264.7 cells 
when stimulated with RANKL in the presence or absence of the different ADO receptors 
agonists used in the experiment, differentiated osteoclasts were identified as TRAP+ 
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multinuclear cells. RAW264.7 cells cultured for 6 days were fixed (5% formalin-saline) 
then stained for TRAP using a TRAP-staining kit, following the manufacturer’s protocol 
(Sigma, St. Louis, MO). Nuclear counter staining was done using methyl green staining. 
The plates were then washed, dried and viewed using the EVOS XL digital inverted 
phase contrast microscope (Advanced Microscopy Group, Bothell, WA, USA). TRAP+ 
cells containing more than 3 nuclei (multinuclear) were counted using 20X objectives. 
b. Pit formation assay 
 RAW264.7 cells cultured on Osteo Assay surface plates were incubated in 100 
"l/well of 10% bleach (NaOCL) for 5 minutes to facilitate cell detachment from the plate 
surface. The plates were then washed with water and dried. Photomicrographs were 
captured using EVOS XL microscope. The captured digital image was transferred and 
saved in Adobe Photoshop CS5 software (Adobe Systems, San Jose, CA). Briefly, 
Images were captured in five areas using 20X objective. They were transferred to 
imaging software and areas of pitting were measured and represented in mm2. 
RANKL production by activated T-cells: 
a. T-cells isolation and culture 
 T-cells were isolated from the spleen and cervical lymph nodes of wild-type 
C57BL/6J mice via negative selection using MACS beads (MACS Pan T cell isolation 
kit, Miltenyi Biotec, Auburn, CA, USA). The resulting enriched T-cell suspension showed 
more than 95% of CD3+ T-cells as analyzed by flow cytometry cell sorting. The isolated 
T-cells (2&105 cells/well) were stimulated with plate-bound anti-mouse #-TCR antibody 
and anti-mouse CD28 antibody (BD Biosciences) with or without NECA treatment.  The 
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supernatant was collected after 48 hours of T-cell stimulation and saved for sRANKL 
ELISA. 
b. ELISA 
 sRANKL levels in T-cells culture supernatants were determined using 
commercially available ELISA kits (R&D Systems, Inc., Minneapolis, MN, USA). 
c. Thymidine incorporation assay 
 This assay employs an approach whereby 3H-thymidine (radioactive nucleoside) 
is incorporated into newly formed strands of DNA chromosomes throughout mitotic cell 
division. A scintillation beta-counter is used to detect and measure incorporation and 
radioactivity of a radiolabeled DNA strands with 3H-thymidine produced during cell 
mitosis. 
In-vivo methods: 
Animals: 
 Black wild-type (WT) mice (C57BL/6J) and CD73-/-Foxp3-GFP+/+ (C57BL/6J-
background) mice were used in this study (8 weeks; body weight 25-30 g). WT mice 
were obtained from Jackson Laboratory (Bar Harbor, Maine, USA) and CD73-/-Foxp3-
GFP+/+ congenic mice were generated in Dr. Kawai’s lab by cross mating Foxp3-
GFP+/+ and CD73-/- mice until reaching the homozygous targeted genes. Animals were 
housed at the Forsyth animal facility in cages having filtered air circulation system in 
order to maintain a specific pathogen free (SPF) environment. Temperature was kept at 
70 +/- 5 degrees Fahrenheit and 50 +/- 20% relative humidity. A 12-hour light/dark cycle 
was maintained. Animals were fed with a standard rodent chow. The Institutional Animal 
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Care and Use Committee (IACUC) approved all procedures used in this study at the 
Forsyth Institute prior to all experiments. 
Development of CD73-/-Foxp3-GFP+/+ congenic mice: 
 CD73-/- mice were generously donated by Dr. Linda Thompson from Department 
of Microbiology & Immunology, University of Oklahoma Health Sciences Center. CD73-/-
Foxp3-GFP+/+ congenic mice were generated by crossing CD73-/- mice with Foxp3-
GFP+/+ mice in the animal facility at the Forsyth institute. The primers sequences for 
genotyping were as the following: 
CD73-/- 1: GCT ACT TCC ATT TGT CAC GTC C 
CD73-/- 2: GTT TTG ATG CGT TCT GCA AG 
CD73-/- 3: TAC CGT TGG CTG ACC TTT GT 
Foxp3 KI-F: CAC CTA TGC CAC CCT TAT CC 
Foxp3 KI-R: ATT GTG GGT CAA GGG GAA G 
Induction of periradicular lesion: 
 Periradicular lesions were initiated by pulp exposure of the mandibular first molar 
pulp of 8-week-old C57BL/6J mice or CD73-/-Foxp3-GFP+/+ mice (C57BL/6J 
background). Mice were anesthetized by intraperitoneal injection of Ketamine HCl (80 
mg/kg of body weight) and Xylazine (10 mg/kg) in sterile phosphate-buffered saline 
(PBS). Anesthetized mice were mounted on a jaw retraction board, and the operation 
was carried out under a surgical microscope (model MC-M92; Seiler, St. Louis, MO). All 
lower first molar pulps were exposed to the oral environment by means of a #1/4 round 
bur as described by Wang and Stashenko [9]. The exposure size was approximately 
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equivalent to the diameter of the bur. The pulp chamber was opened until the orifice of 
the canals could be visualized and probed with a No. 6 endodontic K file. Exposed teeth 
were left exposed to the oral environment during the entire experiment. Mice without 
pulp exposure were used as a negative control in each group. 
Bacteria: 
 Pasteurella Pneumotropica (Pp) is a commensal mouse oral cavity bacterium, 
which is phylogenically closely related to Aggregatibacter actinomycetemcomitans, a 
human pathogen for localized aggressive periodontitis. It was reported that immune 
response against this microorganism elicits periodontal bone loss based on the RANKL 
expression from activated T cells [66]. Bacteria located in the exposed pulp were 
collected using paper points (Tulsa Dental Supply, USA) to confirm the colonization of 
Pp in root canal, followed by the cultured on Pp selection agar that contains vancomycin 
and bacitracin at 37ºC in CO2 incubator. The results of this protocol produced a 
reproducible infection of the root canal system. 
Systemic administration of ADO receptor agonist (NECA): 
 Systemic administration of non-selective adenosine receptor agonist NECA 
(Sigma-Aldrich,  St. Louis, MO) began on the day of pulp exposure by 0.1mg/kg/day, i.p. 
injuction (n=5/group) in the gain-of-function experiment. The other group in this 
experiment received i.p. injections of PBS in the same volume (n=5/group) to 
standardize the stress levels induced during injections and minimize any confounding 
factors. 
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Sample preparation: 
 WT and CD73-/-Foxp3-GFP+/+ mice were randomly assigned into 4 different time 
point groups (n=15/group). Three groups received pulp exposure at the first molars 
(both left and right) of mandibular jaw. Mice were sacrificed at 7, 14 and 21 days from 
the pulp exposure. Control non-treated mice represented day 0. Mandibular jaws were 
collected from the mice sacrificed at the respective time points (0, 7, 14 and 21 days) for 
morphologic, histologic and molecular evaluation. The mandible was hemisected and 
the left side mandibular jaw was immediately frozen at '70°C for ATP detection and 
RNA extraction. The right side of the mandible was defleshed, rinsed with PBS and 
fixed in 4% paraformaldehyde solution over-night. After extensive washing under 
running water for 1 to 3 hours, the fixed jaw was subjected to micro-computed 
tomography ("CT) prior to decalcification and histological evaluation. Spleen and 
cervical lymph nodes were also isolated from mice after the sacrifice at each time point. 
Assessment of the bone destruction: 
 Evaluation of periradicular bone resorption using a micro-computed tomography 
("CT) was done following the protocol published by Balto et al. [67]. The fixed right side 
hemimandibular samples from C57BL/6 wild type mice and CD73-/-Foxp3-GFP+/+ mice 
were analyzed using a compact fan-beam-type tomograph optical computed-
tomography ("CT40, Scanco Medical AG, Basserdorf, Switzerland) at the Forsyth 
microCT core. The µCT system provides a 10 µm nominal resolution. The imaging 
parameters were as follows:  Tube voltage 70 kVp; current 140 mA; and integration time 
300 ms. For each sample, approximately 150 micro-tomographic slices with an 
increment of 17 µm, covering the entire width of the hemimandible.  The data were 
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exported into DICOM format and resliced following a standardized protocol using 
ImageJ® to obtain pivotal sections which included the crown and distal roots. Coronal 
pictures showing patent distal root canal apex were selected and exported in JPEG 
format. In order to quantify the two-dimensional aspect of periradicular bone resorption 
area, a standard template was applied on all pictures. The periradicular area was 
measured using Adobe Photoshop CS5 (Adobe Systems, San Jose, CA). Results of 
two-dimensional aspect of periradicular bone resorption area were expressed in square 
millimeters (mm2). 
Histological sample preparation: 
 After acquiring the "CT images, the right side of WT and CD73-/-Foxp3-GFP+/+ 
mice hemimandibles were decalcified using 10% ethylenediaminetetraacetic acid 
(EDTA) for 14 days in 4ºC temperature cold room over test tube rocker. EDTA solution 
was replenished every other day. The samples were then embedded in paraffin or 
frozen OCT compound (Tissue-Tek®, Sakura Finetek USA inc) for 
Immunohistochemical and immunofluorescence staining, respectively. 
Immunohistochemical staining: 
 Paraffin embedded samples of WT and CD73-/-Foxp3-GFP+/+ mice were cut into 
serial sections at 6 µm thickness; every fifth sample was mounted and stained with 
Hematoxylin and Eosin (H&E) for morphological evaluation. Sections showing the 
region of interest (mesial and distal roots with periradicular lesion) were then selected 
and mounted. 
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Immunofluorescent Laser-Scanning confocal microscopy: 
 Frozen tissue sections embedded in OCT compound were cut (8 µm thickness) 
using a cryostat. Sections showing the region of interest (mesial and distal roots with 
periradicular lesion) were then mounted and kept at a temperature of -20°C. When 
needed, sections were washed with 0.5% bovine serum albumin (BSA), blocked with 
5% BSA and left in humid chamber for 1 hour. Slides were then washed with 0.5% BSA 
and reacted with primary antibodies. Otherwise, control nonimmunized rabbit or goat 
IgG was used as a negative control. Primary antibodies were incubated in humid 
chamber at 4°C for overnight. On the following day, after washing the slides with 0.5% 
BSA, appropriate secondary antibodies were applied, respectively, and incubated for 2 
hours in dark humid chamber at room temperature. Next, slides were washed with 0.5% 
BSA and subjected to counter nuclear staining. Mounting solution for 
immunofluorescent staining (Fluoromount G) was applied to place cover glass on the 
slide. Fluorescent images were captured by 0.3 um sequential optical sectioning using a 
confocal microscope (Zeiss LSM 780). 
TRAP staining for osteoclasts in periradicular bone: 
 In order to identify the presence of osteoclast cells in the periradicular tissues of 
mice, paraffin embedded sections of both WT and CD73-/-Foxp3-GFP+/+ mice were 
stained using a TRAP staining kit following manufacturer protocol (Sigma, St. Louis, 
MO), followed by nuclear counterstaining with hematoxylin. 
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ATP detection and levels in the periradicular lesions: 
 In order to monitor the kinetics of eATP, isolated samples were prepared for the 
bioluminescence assay for quantitative detection of ATP. The tissue samples were 
homogenized and crushed in a 200 "l of PBS using mortar and pestle. Ten "l of this 
homogenized tissue sample were added to 100 "l of the reaction reagents (containing 
0.5 mM D-luciferin, 1.25 "g/mL firefly luciferase, 25 mM Tricine buffer, pH 7.8, 5 mM 
MgSO4 , 100 "M EDTA and 1 mM DTT) and compared to the manufacturer’s standard. 
The total volume in each well of the Optilux Black/Clear Flat Bottom plate was 110"l. 
Plate luminescence was measured after a 15-minute incubation period using the 
Synergy™ HT Multi-Mode Microplate Reader. 
mRNA extraction from bone using a high speed homogenizer 
 Fresh samples of left side hemimandible were rinsed in PBS. The periradicular 
tissues surrounding the mesial and distal root apices were carefully extracted together 
with surrounding bone, in a block specimen under a surgical microscope. Periradicular 
tissues were rinsed in PBS, freed of clots, weighed, and immediately frozen at '70°C. 
The frozen sample was transferred to a pre-cooled Lysing matrix A tubes (MP 
Biomedical, Santa Ana, CA) containing 1 ml Trizol® reagent (Invitrogen, Carlsbad, CA). 
The contents in the tube were disrupted using a high speed homogenizer, FastPrep®-24 
Instrument (MP Biomedical), for 30 seconds for 2 cycles with flakes of dry ice to 
maintain the temperature inside the homogenizer. After addition of chloroform (20% of 
total volume), the samples were centrifuged then transferred to RNA isolation tube 
(Phase-lock gel tube; 5 prime) and subjected to centrifugation for 5 minutes. The 
separated clear aqueous phase solution that contains RNA was mixed 1:1 with 
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isopropanol 99.5% (RNA/DNA-free) to separated RNA as insoluble component. After 
RNA dehydration and precipitation, separated RNA was washed with 70% ethanol. The 
resulting RNA pellet was air-dried and resuspended in DNA free water. The mixture was 
then treated with Turbo DNase™ (Ambion) to completely digest any DNA contamination 
following manufacture protocol. RNA samples were then tested for purity and quantified 
using Nanodrop 2000c spectrophotometers (Thermo Scientific, Cambridge, MA). Only 
samples that showed 260/280 ratios of 1.8-2.2 were used for qPCR. 
Quantitative polymerase chain reaction (qPCR) 
 Complimentary DNA (cDNA) was synthesized using 1 "g of total RNA using 
iScript® cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) by addition of reverse 
transcriptase (0.5 "l) in a total 20 "l of solution. qPCR was performed using 
LightCycler® 480 system (Roche applied science,  Penzberg, Germany) with LightCycler 
480 Sybr 1 master mix (Roche) for 50 cycles.  The PCR cycling profile, as shown in the 
Roche manual and following the manufacturer’s instructions for primers, consisted of an 
initial denaturation step at 95°C for 5 min, followed by 50 cycles of denaturation at 95°C 
for 15s, and annealing/extension 58-60°C for 60s. Melting Curve analysis was also 
performed using a single cycle of 95°C for 20s; 60°C for 20s; 40°C for 1s and 95°C prior 
to the final cooling. 
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The primers that were used during this experiment are: 
Name Source Size(bp) Forward Sequence 5’-3’ Reverse Sequence 5’-3’ 
Actb Real time 
primers 
160 AAGAGCTATGAGCTGCCTGA TACGGATGTCAACGTCACAC 
RANKL Real time 
primers 
239 AATTCCCCTGAAGGTACTCG TCCTTTTTGGCTATGTCAGC 
TNF-! Real time 
primers 
201 CCCACTCTGACCCCTTTACT TTTGAGTCCTTGATGGTGGT 
TGF-" Real time 
primers 
162 GCTACCATGCCAACTTCTGT CGTAGTAGACGATGGGCAGT 
IL-1 " Real time primers 180 CCCAACTGGTACATCAGCAC TCTGCTCATTCACGAAAAGG 
IL-6 Real time 
primers 
187 CTACCCCAATTTCCAATGCT ACCACAGTGAGGAATGTCCA 
IL-10 Real time 
primers 
250 AGTGGAGCAGGTGAAGAGTG TTCGGAGAGAGGTACAAACG 
CD73 Real time 
primers 
179 
156 
AGTCCAACCTCTCGCCTACT 
TCTGCAGCAAGTCAT TACCA 
ATGACTCACCAAAGGCACAT 
CAGGTCTCCAGAGGCAGATA 
CD39 Real time 
primers 
166 
228 
TCTTAAACACCCTTCCACCA 
AGACAGACGAGGGAAGAGGA 
TGGTGCCTAATTGTCTCCAT 
CAGGTTGGTGTGAGATGACC 
Alpl Real time 
primers 
245 
158 
TCTGCTCAGGATGAGACTCC 
ACGAATCTCAGGGTACACCA 
TCCCTTTTAACCAACACCAA 
TGAGCTTTTGGAGTTTCAGG 
Runx2 Real time 
primers 154 CCACCTTCATTTGAATCCTG GTTGGAGGCACACATAGGTC 
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Statistical analyses: 
 Simple univariate descriptive statistics in proportions, mean, median standard 
deviation and Standard error, where appropriate, was used to describe the dependent 
and independent variables of interest. Statistical significance between two groups was 
calculated using Student's t-test. Data from multiple-group experiments was analyzed 
by one-way ANOVA and post-hoc Tukey honestly significant difference (HSD). 
Bonferroni correction was used to adjust for possible Type-1 errors resulting from 
multiple comparisons. A p-value less than 0.05 was considered statistically significant. 
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Results: 
I. In-vitro investigation to explain the role of nucleotides in RANKL mediated 
osteoclastogenesis: 
1. The effects of ADO and ADO receptor agonist (NECA) on RANKL induced 
osteoclastogenesis (Number of TRAP+ cells): 
 In order to measure the mature osteoclasts differentiated from RAW264.7 cells 
when stimulated with RANKL (50 ng/ml) in the presence or absence of the 3 different 
ADO receptors agonists used in the experiment, differentiated osteoclasts were 
identified as TRAP+ multinuclear cells (cells containing more than 3 nuclei were 
counted).  
 A concentration of 1 or 10 nM of all 3 ADO receptor agonists used did not 
significantly affect the number of TRAP+ cells. However, a statistically significant higher 
number of TRAP+ cells were observed when concentrations of 100 and 1000 nM of 
both IB-MECA and CCPA were added. In contrast, concentrations of 100 and 1000 nM 
of NECA significantly lowered the number of TRAP+ cells. (Figure 1) 
2. The effects of ADO and ADO receptor agonist (NECA) on RANKL induced 
osteoclastogenesis (pit formation assay): 
 In order to evaluate the effect of NECA on the function of mature osteoclast cells, 
we performed pit formation assays using RANKL-stimulated RAW 264.7 as the source 
of mature osteoclasts.  RAW 264.7 precursor cells that were stimulated with RANKL (50 
ng/ml) and 3 different concentrations of NECA (10, 100, and 1000 nM) were added to 
Corning® Osteo Assay Surface (calcium phosphate-coated culture dishes to mimic the 
bone environment). The area of resorption on the plate surface was calculated. 
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 The negative control group not stimulated with 50 ng/ml rRANKL showed no pit 
formation, as expected. Moreover, when the cells were treated with 10 nM of NECA, no 
difference was observed, confirming the results from the prior TRAP+ experiment. On 
the other hand, a significant decrease in osteoclastic activity occurred when cells were 
treated with 100 and 1000 nM of NECA by showing a smaller area of resorbed pits. 
(Figures 2 & 3) 
3. The effects of ADO and ADO receptor agonist (NECA) on RANKL production by 
activated T-cells 
 RANKL ELISA assay was performed on the culture supernatant of primary 
mouse T-cell cultures stimulated with anti-#TCR MAb and anti-CD28 MAb in the 
presence or absence of NECA (1, 10, 100 and 1000 nM). All 4 concentrations of NECA 
significantly suppressed the production of RANKL, showing downregulation of 
osteoclastogenesis and inhibition of osteoclastic activity. (Figure 4) 
 3-H-thymidine radioisotope was added to the plates after collecting the culture 
supernatant. The plates were incubated in optimal conditions (37°C and 5% CO2) for 24 
hours. A concentration of 1 nM NECA had no effect on the proliferation of T 
lymphocytes; however, all other concentrations (10, 100, and 1000 nM) significantly 
downregulated the proliferation of T lymphocytes. (Figure 5) 
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II. ATP kinetics in mouse periradicular lesions: 
 In order to monitor the kinetics of eATP, isolated samples were prepared for the 
bioluminescence assay for quantitative detection of ATP. The plate luminescence was 
measured after a 15-minute incubation period using the Synergy™ HT Multi-Mode 
Microplate Reader. A statistically significant difference was noted between wild-type 
(WT) mice and CD73-/-Foxp3-GFP+/+ mice at all 3 time points (7, 14, and 21 days). More 
specifically, an increase of ~10% in ATP expression levels was seen in KO mice when 
compared to WT mice at day 7. The difference was higher on day 14 with an increase of 
~15%. Finally, on day 21, samples showed an increase in ATP production by ~20% in 
KO mice compared to WT. (Figure 6). 
III. ADO loss of function effects on mouse periradicular lesion:  
1. The effect of CD73 gene knockout on pulp exposure induced bone resorption 
! H&E staining: (Figures 7 & 8) 
 In order to evaluate the effect of ADO on proinflammatory status and the 
development of periradicular lesions, histomorphological paraffin sections of 
periradicular lesion (day 0, 7, 14, and 21) of both CD73-/-Foxp3-GFP+/+ and WT mice 
were evaluated and compared. 
 Histomorphological analysis of nonexposed teeth (day 0) served as a control to 
show the baseline of the periradicular area, periodontal ligament, and nature of 
inflammatory cells around the tooth apex. 
 An expansion and destruction of the periodontal ligament was observed in the 
periradicular area. This expansion significantly increased on days 7, 14, and 21. This 
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destruction was more evident in CD73-/-Foxp3-GFP+/+ mice.  At days 14 and 21, diffuse 
inflammatory cell infiltration could be observed. Particularly, infiltration of PMNs was 
clearly noted in the CD73-/-Foxp3-GFP+/+ group when compared to WT. This suggests 
that the absence of ADO and accumulation of ATP in the periradicular area could 
upregulate the mediation of proinflammatory cytokines and attract inflammatory cells. 
Periradicular bone destruction was also significantly greater at all time points in the 
CD73-/-Foxp3-GFP+/+ mice.  
! TRAP staining: (Figures 9, 10 & 11) 
 There was significantly higher number of TRAP+ cells were observed in the 
periradicular area of CD73-/-Foxp3-GFP+/+ mice in all time points. 
! Immunofluorescence staining: (Figure 12) 
 Immunofluorescence staining of periradicular lesion of day 21 WT mice with 3 
antibody staining: DRAQ5 for nucleus, FITC for Foxp3+, and Alexa Flour 594 for CD73. 
Yellow areas seen in the confocal microcopy images are double positive stained with 
FITC and Alexa Flour 594 confirming that Foxp+ Treg cells express CD73. 
! "CT analysis: (Figures 13 & 14) 
 Periradicular lesions were initiated by pulp exposure of the mandibular first molar 
pulp of 8-week-old C57BL/6J mice or CD73-/-Foxp3-GFP+/+ mice (C57BL/6J 
background) at 4 different time points: 0, 7, 14, and 21 days (n=10/group). Mandibular 
jaws were collected from mice sacrificed at respective time points (0, 7, 14 and 21 days) 
and hemisectioned. The right side of the hemisectioned mandible was defleshed, rinsed 
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with PBS and fixed in 4% paraformaldehyde solution overnight. After extensive washing 
under running water for 1 to 3 hours, the fixed jaw was subjected to micro-computed 
tomography ("CT) using compact fan-beam-type tomograph ("CT40, Scanco Medical 
AG, Basserdorf, Switzerland) at the Forsyth microCT core facility following Balto et al. 
[67]. 
 The size of the periradicular lesions in CD73-/-Foxp3-GFP+/+ mice significantly 
increased at days 7, 14, and 21. More specifically, the size of periradicular lesions 
increased in CD73-/-Foxp3-GFP+/+ mice when compared to WT mice in groups sacrificed 
at days 7, 14, and 21 by 0.084, 0.072, and 0.184 mm2, respectively. 
2. Detection of mRNA expression for CD39, CD73, proinflammatory, anti-inflammatory 
cytokines, osteoclast and osteoblast differentiation markers. 
 In order to assess the effect of CD73 gene knockout (loss-of-function) on the 
inflammatory process in periradicular lesions, left hemimandibles were isolated from 
euthanized WT and CD73-/-Foxp3-GFP+/+ mice at days 0, 7, 14 and 21 (n=10/group). 
The bone block was trimmed to include only the root apices of the first molars after 
decoronation of the coronal part of the tooth. mRNA extraction was performed, as 
shown in Material and Methods. Gene expression of CD73, CD39, IL-1#, IL-6, TNF-$, 
TGF-#, RANKL, OPG, ALP, and RUNX2 mRNA was evaluated by qPCR using #-actin 
as an internal control. 
a) CD73 and CD39: 
 The expression of CD73 in WT mice showed significant increase on days 14 and 
21 in a time-dependent manner, suggesting host defense against the inflammatory 
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process (Figure 15). Meanwhile, the expression of CD39 in WT mice showed a trend of 
gene overexpression in a time-dependent manner, even though statistically significant 
increase was only observed on day 21. When CD39 expression was evaluated in CD73-
/-Foxp3-GFP+/+ mice, results showed an increase in gene expression in a time-
dependent manner with statistically significant difference seen on days 14 and 21. 
When data from both WT and CD73-/-Foxp3-GFP+/+ mice were compared, CD39 
expression was slightly higher in CD73-/-Foxp3-GFP+/+ with no statistically significant 
difference (Figure 16). In general, these findings indicate that the immune system is 
trying to prevent ATP accumulation in periradicular lesions by upregulating CD73 and 
CD39 with the objective of increasing the production of ADO. 
b) Proinflammatory mediators: 
 The expression pattern of IL-1# mRNA in the periradicular lesions of WT and 
CD73-/-Foxp3-GFP+/+ mice showed statistically significant increase at all three time 
points (7, 14, 21 days) when compared to the nonexposed control samples. However, 
when WT and CD73-/-Foxp3-GFP+/+ mice were compared to each other, statistically 
significant difference was only observed on day 14 and 21 (Figure 17). 
 A time-dependent pattern of IL-6 gene expression was displayed in the 
periradicular lesions of WT and CD73-/-Foxp3-GFP+/+ mice; however, this increase was 
only statistically significant on day 21. When evaluating the difference between WT and 
CD73-/-Foxp3-GFP+/+ mice, a huge increase of IL-6 expression was noted in KO mice, 
especially on days 14 and 21 (Figure 18). 
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 The expression of TNF-$ mRNA in the periradicular lesions of WT mice showed 
a spike on day 7. Following this, expression dropped on day 14, but increased on day 
21. On the other hand, the expression levels in CD73-/-Foxp3-GFP+/+ mice were higher 
at all-time points and reached a plateau at day 14. Most importantly, a noticeably higher 
expression of TNF-$ was observed in CD73-/-Foxp3-GFP+/+ mice, especially on days 14 
and 21 (Figure 19). 
 Generally, these findings underscore the importance of CD73 and ADO in 
minimizing the overexpression of proinflammatory cytokines in periradicular lesions. 
c) Anti-inflammatory mediators: 
 The expression pattern of TGF-# mRNA in the periradicular lesions of WT and 
CD73-/-Foxp3-GFP+/+ mice showed significant increase at the 14- and 21-day time 
points when compared to nonexposed control samples. However, no difference was 
detected between WT and CD73-/-Foxp3-GFP+/+ mice (Figure 20). 
d) Osteoclast differentiation factors: 
 Although no difference in OPG mRNA expression was detected between WT and 
CD73-/-Foxp3-GFP+/+ mice (Figure 21), upregulation of RANKL showed statistically 
significant difference in CD73-/-Foxp3-GFP+/+ mice (Figure 22). 
e) Osteoblast differentiation factors: 
 A time-dependent pattern of gene expression of RUNX2 mRNA was displayed in 
the periradicular lesions of WT mice; however, this increase was only statistically 
significant on day 14. On the other hand, the expression of RUNX2 in the periradicular 
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lesions of CD73-/-Foxp3-GFP+/+ mice showed no change at day 7 compared to the 
nonexposed control group.  RUNX2 expression then spiked on day 14. Following this, a 
slight drop in expression was detected at day 21. Notably, no significant difference in 
RUNX2 production was observed between WT and CD73-/-Foxp3-GFP+/+ mice (Figure 
23). 
 A time-dependent increase in gene expression pattern of alkaline 
phosphatase (ALP) was displayed in the periradicular lesions of WT mice; however, this 
increase was not statistically significant. Meanwhile, the expression of ALP in the 
periradicular lesions of CD73-/-Foxp3-GFP+/+ mice showed no change on day 7 
compared to the nonexposed control group. However, ALP expression spiked at day 14. 
Following this, a slight drop in expression was detected at day 21. Notably, no 
significant difference in ALP production was seen between WT and CD73-/-Foxp3-
GFP+/+ mice (Figure 24). 
IV. ADO gain of function effects on mouse periradicular lesion: 
1. The effect of NECA administration on pulp exposure induced bone resorption: 
 A total of 15 black wild-type (WT) mice (C57BL/6J) were used in this experiment 
(8 weeks; body weight 25-30 g). Mice were anesthetized by intraperitoneal injection of 
Ketamine HCl (80 mg/kg of body weight) and Xylazine (10 mg/kg) in sterile phosphate-
buffered saline (PBS). Periradicular lesions were initiated by pulp exposure of the 
mandibular first molar pulp. On the day of pulp exposure, NECA at 0.1mg/kg/day was 
systemically administered i.p. (n=5/group). The other group received i.p. injections with 
the same volume of PBS (n=5/group) to standardize the stress levels induced during 
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injections and minimize any confounding factors. Finally, the last five mice without pulp 
exposure were used as negative control (n=5/group). All mice were sacrificed on day 
21, and samples were immediately collected. Mandibular jaws were collected from the 
mice sacrificed for morphologic, histologic and molecular evaluation. The mandible was 
hemisected, and the left side mandibular jaw was immediately frozen at '70°C for RNA 
extraction. The right side was defleshed, rinsed with PBS and fixed in 4% 
paraformaldehyde solution overnight. After extensive washing under running water for 1 
to 3 hours, the fixed jaw was subjected to micro-computed tomography ("CT) prior to 
decalcification and histological evaluation. 
 The fixed jaw was subjected to micro-computed tomography ("CT) using a 
compact fan-beam-type tomograph ("CT40, Scanco Medical AG, Basserdorf, 
Switzerland) at the Forsyth microCT core facility following Balto et al. [67]. The "CT 
results showed a significant decrease in the size of the periradicular lesions when 
NECA was administered. The difference in the size of periradicular lesions was 
statistically significant with ~2.5-fold decrease. (Figures 25 & 26) 
2. Detection of mRNA expression for pro-inflammatory, anti-inflammatory cytokines, 
CD39, CD73, and CD73 receptors in periradicular lesions: 
 In order to evaluate the effect of NECA administration (gain-of-function) on the 
inflammatory process in periradicular lesions, left side hemimandibles were isolated 
from euthanized mice at day 21 (n=5/group). The bone block was trimmed to include 
only the root apices of the first molars after decoronation of the coronal part of the tooth. 
mRNA extraction was performed as shown in material and methods. Gene expression 
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of CD73, CD39, IL-1#, IL-6, TNF-$, TGF-#, RANKL, ALP, and RUNX2 mRNA was 
evaluated by qPCR using #-actin as an internal control. 
a) CD73 and CD39: (Figures 27 & 28) 
 The expression of CD73 mRNA and CD39 mRNA in NECA-treated mice showed 
significant increase (P<0.01) suggesting host defense against the inflammatory process. 
Generally, these findings highlight the prevention of ATP accumulation in the 
periradicular lesions by upregulating CD73 and CD39 to allow for increased production 
of ADO. 
b) Proinflammatory mediators: (Figures 29, 30 & 31) 
 The expression of mRNAs for IL-1#, IL-6, and TNF-$ in the periradicular lesions 
of NECA-treated mice showed downregulated gene expression. However, statistical 
significance was only detected in IL-1# gene expression (P<0.01). These data 
underscore the importance of ADO in modulating host response and preventing the 
influx of proinflammatory mediators to the periradicular area. 
c) Anti-inflammatory mediators: (Figure 32) 
 The expression of TGF-# mRNA in the periradicular lesions of NECA-treated 
mice showed the same levels of gene expression when compared to nontreated mice. 
d) Osteoclast differentiation factors: (Figure 33) 
 The expression levels of RANKL mRNA in periradicular lesions of NECA-treated 
mice were significantly lower (P<0.01). These data highlight the critical role of ADO in 
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downregulating the expression of this gene encoding osteoclast differentiation factor, 
RANKL. 
e) Osteoblast differentiation factors: (Figures 34 & 35) 
 The expression of RUNX2 mRNA in periradicular lesions of NECA-treated mice 
showed higher gene expression; however, this increase was not statistically significant. 
On the other hand, the expression of ALP in periradicular lesions of NECA-treated mice 
showed a significant increase by 3-fold when compared to nontreated mice. 
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Comparison between the effects of CD73 gene knock-out (loss of ADO function) 
and NECA-treated mice (gain of function): 
 
CD73-KO                 NECA-treated 
Proinflammatory cytokines 
IL-1# (+) (-) 
IL-6 (+) NS 
TNF-$ (+) NS 
Anti-inflammatory cytokines 
TGF-# NS NS 
Osteoblast differentiation factors 
RUNX2 NS NS 
ALP NS (+) 
Osteoclast differentiation factors 
RANKL (+) (-) 
OPG NS NS 
Ectoenzymes 
CD73 Knocked-out (+) 
CD39 NS (+) 
 (+)    upregulated (P < 0.05) 
 (-)     downregulated (P < 0.05) 
 (NS) No statistical significance detected 
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Discussion: 
 Despite increased understanding on the effects of bacteria-derived PAMPs on 
the etiology of periradicular periodontitis [68-72], the role of damage-associated 
molecular pattern molecules (DAMPs) that are released from host immune surveillance 
cells in the context of periradicular periodontitis is largely unknown. It is plausible that, in 
response to bacterial challenge, DAMPs released from damaged host cells are involved 
in the up-regulation of inflammation in the context of infection [73-76], the theory of 
which can be applied to the periradicular periodontitis. However, among a panel of 
DMAPs that are thus far reported to be released from damaged host cells, 
extracellularly released ATP, ADO, and other purine metabolites have relatively recently 
identified as DAMPs [77-80]. For this reason, the possible engagements of ATP and 
ADO in the inflammatory bone resorption processes in periradicular periodontitis have 
been largely unknown until this study. The present study, for the first time, addressed 
and established the pathophysiological roles of ATP and ADO in the context of 
periradicular periodontitis. 
 In this study, we have investigated the roles of purine family DAMPs, ATP and 
ADO, and CD73 ectonucleotidase, the enzyme that catalytically converts ATP-
metabolite AMP to ADO in the pathogenically dysregulated bone remodeling processes 
of periradicular periodontitis using a mouse model. CD73-/-Foxp3-GFP+/+ mice showed 
significantly elevated inflammatory response after the induction of periradicular 
periodontitis compared to that induced in wild-type mice (Figures 17, 18 & 19). Also, the 
number of TRAP+ multinucleated osteoclastic cells in the periradicular area as well as 
the size of bone loss was significantly larger in the CD73-KO mice than those detected 
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in WT mice (Figures 11 & 14), suggesting that CD73 is engaged in the suppression of 
osteoclast-mediated bone resorption. Furthermore, CD73 expression was 
predominantly found on Foxp3+ Treg cells, but not on the other cell types, in the mouse 
periradicular lesion (Figure 12). All of above noted findings supported our hypothesis 
that extracellular adenosine (eADO) produced by CD73+Foxp3+ Treg cells may play a 
counter-regulatory role in bone resorption induced in periradicular periodontitis. 
The role of purine nucleotides in induction of inflammatory response in 
periradicular periodontitis: 
 The pathogenic bone resorption occurring in periradicular periodontitis is a 
multifactorial process. Pro-inflammatory cytokines and immune cells are critical players 
in this task [81-86].  However, besides bacterial PAMPs, the upstream molecular events 
that elicit the production of inflammatory factors and activate immune cells are largely 
unknown. While consensus support that bacterial PAMPs trigger the inflammatory 
immune responses in most cases of periradicular periodontitis [68-70], it is also true 
that, even after the successful disinfection of root canal system by virtue of root canal 
antibacterial procedure, inflammation and bone resorption process in the periradicular 
periodontitis are retained [87-89], suggesting the presence of endogenous factor(s) that 
can activate the inflammatory immune responses in addition to latent bacterial infection. 
For this reason, we explored pathophysiological effects of purine metabolites as most 
abundant DAMPs that are released by host cells in response to bacterial infection.  
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In this study, it was demonstrated that the CD73 expressed on Treg cells can convert 
proinflammatory ATP to anti-inflammatory ADO that, in turn, suppressed RANKL-
mediated osteoclastogenesis and RANKL production by activated T-cells (Figure 22). 
CD39/CD73 adenosinergic machinery changes dynamically the property of 
proinflammatory ATP [90, 91]. More specifically, CD39 exonucleases convert 
proinflammatory ATP to AMP which is, in turn, transformed to anti-inflammatory ADO by 
means of CD73’s nuclease activity [43, 91]. Most importantly, Foxp3+ Treg cells co-
express CD39 and CD73 [63, 90], while both CD39 and CD73 are also reported to be 
expressed by endothelial cells [92, 93].  It is becoming increasingly recognized that 
altering this CD39/CD73 machinery can change the course several pathophysiological 
events, such as AIDS, autoimmune diseases, infections, atherosclerosis, ischemia-
reperfusion injury, and cancer  [94-102]. In this regard, recent studies revealed that Tregs 
cells are the major cellular source for CD73 and CD39 ectonucleotidases in 
inflammatory immune responses [41, 42]. Although the possible engagement of 
CD39/CD73 adenosinergic exonucleases expressed on Treg cells have been largely 
unknown, the present study demonstrated that the CD73 expressed on Treg cells can 
convert proinflammatory ATP to anti-inflammatory ADO that, in turn, suppressed 
RANKL-mediated osteoclastogenesis and RANKL production by activated T-cells. 
The effects of ADO and ADO receptor agonist (NECA) on RANKL induced 
osteoclastogenesis 
 A recent study showed that CD73 produced by Tregs down-regulated the 
production of NF-%B through the activation of adenosine receptor A2A and reducing the 
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production of proinflammatory mediators [44]. Another study highlighted the importance 
of ADO and its receptors in the pathophysiology of bone metabolism and inflammatory 
bone resorption, opening “new areas for exploration in understanding endogenous 
control of bone metabolism” [103]. All of the previous reports clearly concur to our 
results showing that increased level of ADO via CD73 may lead to the inhibition of the 
RANKL-mediated osteoclastogenesis and downregulation of the inflammatory bone 
resorption. 
The effects of ADO and ADO receptor agonist on RANKL production by 
activated T-cells 
 Accumulated lines of evidence support that activated T cells express RANKL in 
the context of periradicular inflammatory bone resorption and the level of RANKL 
production was also directly related to the expansion of periradicular bone loss lesion 
[24, 33, 104]. Several pharmacological agents that suppress the RANKL-induced 
osteoclastogenesis, such as, a cathepsin K inhibitor odanacatib (ODN) [105], 
alendronate [106] and ATP6i-silencing shRNA [107], were demonstrated to suppress 
periradicular bone loss induced in animal models. However, since all of those 
approaches that target only osteoclasts without regulating the production of RANKL by 
activated T cells, it is concerned if those approaches would cause side effects similar to 
MRONJ [108]. Therefore, additional investigations are required prior to the translation of 
those findings into the treatment of human periradicular periodontitis. On the other 
hand, growing evidence emphasizes that ADO receptor agonists especially that target 
A2a receptor may lead to the development of modalities that can suppress pathogenic 
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inflammatory immune responses [109, 110]. It was reported that A2a receptor plays an 
immune-suppressive roles [111], which involve ADO-mediated Treg activation [112, 
113] as well as direct suppression of effector T cells [114].  However, no studies have 
addressed the effect of ADO and its receptors on RANKL production by activated T 
cells. Our results showed that ADO receptor agonist (NECA) significantly suppressed 
the production of RANKL from activated T cells and down-modulated the RANKL-
induced osteoclastogenesis as well as osteoclastic pit-formation activity in vitro (Figures 
2 & 4), suggesting that the approach to activate ADO receptors can suppress the 
pathogenic bone resorption in the periradicular periodontitis by acting on activated T 
cells that produce RANKL. Very importantly, we did not observe any sign of 
osteonecrosis in the mice induced of periapical periodontitis that received systemic 
administration of NECA (data not shown). 
ATP kinetics in mouse periradicular lesions: 
 ATP is one of the most intensively studied molecules in the classical biology.  
Based on ATP’s intracellular roles to store and transfer energy, ATP is known as the 
“energy currency” of cells [115]. However, surprisingly, ATP and other purine 
nucleotides can be released into the extracellular spaces by cell lysis or by non-lytic 
mechanisms under certain conditions [43, 116]. Indeed, the proinflammatory effect of 
extracellular ATP was uncovered by the discovery of ATP receptors expressed on cell 
surface, such as P2X and P2Y [117, 118]. More specifically, ATP elicits a major 
endogenous danger signal via ligation to the purinergic receptors, leading to the 
production of proinflammatory cytokines from surrounding leukocytes, such as T cells 
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and macrophages that express ATP receptors [119-121]. High concentration of ATP in 
the extracellular spaces induce a predominantly proinflammatory effects [116]. Above 
noted earlier studies coincide with our finding that CD73-/-Foxp3-GFP+/+ mice showed 
an accumulation of ATP in the periradicular lesion in a time dependent manner (Figure 
6), probably due to the absence of CD73-dependent catalytic action to convert ATP-
metabolite AMP to ADO. 
Adenosine loss of function model effects on periradicular bone resorption: 
CD73 expression in wild-type periradicular periodontitis: 
 Although there was no studies looked at the presence and function of CD73 in 
the context of oral disease pathogenesis especially periradicular periodontitis, our 
results demonstrated a time dependent increase in the expression of CD73 gene in WT 
mice using qPCR. Moreover, frozen immunofluorescence histological stained sections 
showed clear expression of CD73+ Foxp3+ cells in the periradicular lesions. 
The effect of CD73 gene knockout on pulp exposure induced bone resorption: 
 Previous reports showed that development of periradicular lesions in mouse 
models takes around 72 hours to show innate immune cells migration to the area and 3 
days to show adaptive immune cells migration [12, 122, 123]. The peak of periradicular 
lesion size will reach at day 21 after the pulp exposure [124]. 
 Our data showed that CD73-/-Foxp3-GFP+/+ had significantly higher amount of 
periradicular bone resorption compared to WT mice due to the accumulation of ATP in 
the extracellular spaces. Knockout mice also exhibited more intense inflammatory cells 
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infiltration into the periradicular lesions. Moreover, Knockout mice showed a higher 
number of TRAP+ cells in the periradicular area. 
 Reports in the literature indicated that higher levels of ATP in the tissues with 
diminished amounts of ADO may lead to exaggerated immune response and promoting 
mononuclear cells chemotaxis [43, 103]. Taken together, these findings firmly suggest 
the role of ADO and CD73 in the pathogenesis of periradicular periodontitis and 
subsequent supporting bone loss.  
The effect of CD73 gene knockout on mRNA expression for CD39, proinflammatory, 
anti-inflammatory cytokines, osteoclast and osteoblast differentiation markers: 
! CD39 (Ectonucleoside triphosphate diphosphohydrolase-1): 
 CD39 ectonucleotidase represents the first step in the metabolism of purine 
nucleotides which mainly dephosphorylates extracellular ATP to AMP. CD39 is crucial 
in the conversion of extracellular ATP and catalytic inactivation which is an important 
mechanism of immune suppression [125]. In our results, gene expression was slightly 
higher in CD73-/-Foxp3-GFP+/+ mice with no statistical significant difference in all time 
points. 
! Proinflammatory mediators: 
 There is growing evidence in the literature that CD39 and CD73 expressed by 
Treg cells contribute to local accumulation of adenosine, suppressing proinflammatory 
cytokine production, and attenuation of inflammation [91, 126]. Therefore, increasing the 
levels of ADO in the extracellular spaces will lead to reduction in proinflammatory 
cytokines generation. 
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 Our results as expected match all the previously mentioned studies, showing 
overall increase in the proinflammatory cytokine production in CD73-/-Foxp3-GFP+/+ 
mice by virtue of decrease ADO levels. 
! Anti-inflammatory mediators: 
 The literature shows that anti-inflammatory cytokines levels are directly 
proportional to the levels of CD39 and CD73. Moreover, TGF-# anti-inflammatory 
cytokine signaling directly induce the generation of these ectonucleotidases [127, 128]. 
In our data, although there was a significant increase of TGF-# in days 14 and 21 after 
the pulp exposure, however, there was no statistical difference between the wild-type 
and knockout mice. 
! Osteoclast differentiation factors: 
 There is a consensus in the literature that extracellular ATP stimulates the 
expression RANKL. On the other hand, extracellular ADO will counteract the ATP 
actions and suppress the RANKL expression [103, 129-131]. Our data showed an 
immense increase in RANKL expression in CD73-/-Foxp3-GFP+/+ compared to wild-type 
mice. However, OPG expression didn’t show a statistical difference between the two 
groups in all time points. 
! Osteoblast differentiation factors: 
 There has been an increase interest in the literature to study and explore the 
potential role of ADO in osteoblast differentiation. Recently, studies showed that CD73 
generated ADO regulate the differentiation of osteoblasts through A2B receptor signaling 
[55, 132-134]. However, in our results RUNX2 and ALP didn’t show a significant 
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difference between wild-type and knockout mice although there was a trend of increase 
in the expression of RUNX2 at day 21 in CD73-/-Foxp3-GFP+/+ mice. 
Adenosine gain of function model effects on periradicular bone resorption: 
The effect of NECA administration on pulp exposure induced bone resorption: 
 There was no real interest in the effects of ATP and adenosine in oral 
inflammatory diseases even though these molecules have an important role in pain 
perception and signaling too which is vital element in dental research [131]. Given the 
high number of agonists and antagonists for these molecules, our focus was to develop 
a novel therapeutic regimen for human periradicular periodontitis. 
 In order to choose the best possible agent to modulate the immune response and 
minimize the bone resorption, 3 different adenosine receptor agonists were tested in 
vitro as explained above. NECA exhibited a significant reduction in the osteoclastic 
activity validating testing it in an in vitro model to confirm its action. 
 The mice received intraperitoneal systemic administration of non-selective 
adenosine receptor agonist NECA started at the day of pulp exposure by 0.1mg/kg/day, 
i.p. as shown in the materials and methods section. These mice showed diminished 
amount of periradicular bone resorption confirming the previous in vitro results and 
opening the door for more thorough investigation in this area. Moreover, these mice 
showed a statistical significant decrease in the expression of CD39, CD73, IL-1#, and 
RANKL. Additionally, there was a huge increase in alkaline phosphatase expression 
showing the higher osteoblast activity in NECA treated mice. 
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 Similarly, the literature showed that A2B AR knockout mice exhibited a reduction 
in osteoblast differentiation factors (ALP and RUNX2) [132]. Also, the overall 
proinflammatory and anti-inflammatory effects of NECA reported were very similar to 
our data. Taken together, NECA has the potential to be a key pharmacological element 
used in local immune modulation for therapeutic purposes. 
Conclusions: 
1) According to in vitro assays, adenosine receptor agonist, NECA, significantly 
suppressed not only RANKL-mediated osteoclastogenesis from RAW264.7 cells, but 
also significantly downregulated proliferation and RANKL production from 
TCR/CD28-activated T cells, suggesting that the ADO elicited signal can 
downregulate RANKL-induced osteoclastogenesis.  
2) As determined by qPCR-based in vivo gene expression analysis, the amount of ATP 
and expression of CD73 mRNA were significantly increased in the mouse 
periradicular lesion in a time-dependent manner, indicating that CD73 expression 
may be induced to down-regulate the inflammation that is elicited by elevated ATP.  
3) Systemic administration of NECA to the mice induced of periradicular periodontitis 
significantly upregulated the mRNA expressions for CD39, CD73, alkaline 
phosphatase, and RUNX2, while downregulated the expressions of mRNAs for  
RANKL and IL1-#, accompanied by diminished size of periradicular lesion, 
compared to the control no-drug-treated WT mice that were induced of periradicular 
periodontitis.  These results implicated that activation of ADO receptor-signaling can 
not only suppress the osteoclast-mediated bone resorption, but also promote the 
osteoblastogenic-bone formation. 
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4) Fluorescent immunohistochemical staining of mouse periradicular lesion showed 
that CD73 was prominently expressed by Foxp3+ Treg cells infiltrating in the lesion, 
while modest level of CD73 expression was detected in endothelial cells, suggesting 
Treg cells are the major cellular source of CD73 in the periradicular lesion. 
5) Finally, the locally produced ATP and mRNAs for RANKL, IL1-#, IL-6, and TNF-$, as 
well as the size of periradicular lesions were significantly larger (P<0.05) in CD73-/-
Foxp3-GFP+/+ mice compared to control WT-mice, as periradicular periodontitis was 
induced in those two different mouse strains, supported the role of Foxp3+ Treg cells 
in converting ATP to ADO which, in turn, facilitates the anti-inflammatory effects in 
the context of periradicular periodontitis. 
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Figure 1.    Number of TRAP+ mature osteoclasts differentiated from RAW264.7 cells 
when stimulated with RANKL (50 ng/ml) in the presence or absence of 4 different 
concentrations of 3 different ADO receptors agonists. 
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Figure 2.    Effect of ADO receptor agonist (NECA) on RANKL induced 
Osteoclastogenesis by pit formation assay. *(P < 0.05). 
 
 
 
 
Figure 3.    Photomicrographs of resobed areas in the osteo assay plate by mature 
osteoclasts in 2 different groups. (x40) 
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Figure 4.   ELISA assay was performed on the culture supernatant of primary mouse T-
cell cultures that were stimulated with anti-#TCR MAb and anti-CD28 MAb in the 
presence or absence of NECA 
 
 
Figure 5.    3-H-thymidine radioisotope incorporation assay. *(P < 0.05). 
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Figure 6.    Percentage difference of ATP levels detected in the Periradicular lesions of 
WT and KO mice at different time points post pulp exposure. *(n = 7, P < 0.05). 
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A) 
 
B) 
 
Figure 7.    A) photomicrographs of histological sections stained with H&E staining of 
the WT control (non-exposed) mice. B) WT 21 days following pulp exposure. R: Root; 
PA: Periradicular lesion; B: Bone 
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A) 
 
B) 
 
Figure 8.    A) photomicrographs of histological sections stained with H&E staining of 
the KO control (non-exposed) mice. B) KO 21 days following pulp exposure. R: Root; 
PA: Periradicular lesion; B: Bone 
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A) 
 
B) 
 
Figure 9.    A) photomicrographs of histological sections stained with TRAP staining 
and counter satined with hematoxylin of the WT control (non-exposed) mice. B) WT 21 
days following pulp exposure. R: Root; PA: Periradicular lesion; B: Bone; arrows 
indicate the TRAP+ osteoclasts in the lesion. 
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A) 
 
B) 
 
Figure 10.    A) photomicrographs of histological sections stained with TRAP staining 
and counter satined with hematoxylin of the KO control (non-exposed) mice. B) KO 21 
days following pulp exposure. R: Root; PA: Periradicular lesion; B: Bone; arrows 
indicate the TRAP+ osteoclasts in the lesion. 
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Figure 11.    Number of TRAP+ cells in WT and KO mice at different time points. 
*(n = 5, P < 0.05). 
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Figure 12.     Immunofluorescence staining of periradicular lesion of day 21 WT mice 
(Blue: nucleus with DRAQ5, Green: Foxp3 with FITC, Red: CD73 with Alexa Flour 594). 
Yellow areas are double-positive cells stained with FITC and Alexa Flour 594. Green 
area represents the bone. 
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Figure13.    Buccal view slice showing the amount of bone resorption 
 
 
Figure 14.    Quantification of bone resorption by "CT analysis 
*(n = 10, P < 0.05). 
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Figure 15.    CD73 mRNA expression in WT Periradicular lesions showing CD73 gene 
expression fold change relative to beta actin housekeeping gene in multiple time points. 
*(n = 10, P < 0.05). 
 
 
Figure 16.    CD39 mRNA expression in WT and KO Periradicular lesions showing 
CD39 gene expression fold change relative to beta actin housekeeping gene in multiple 
time points. *(n = 10, P < 0.05). 
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Figure 17.    IL-1# mRNA expression in WT and KO Periradicular lesions showing IL-1# 
gene expression fold change relative to beta actin housekeeping gene in multiple time 
points. *(n = 10, P < 0.05). 
 
Figure 18.    IL-6 mRNA expression in WT and KO Periradicular lesions showing IL-6 
gene expression fold change relative to beta actin housekeeping gene in multiple time 
points. *(n = 10, P < 0.05). 
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Figure 19.    TNF-$ mRNA expression in WT and KO Periradicular lesions showing 
TNF-$ gene expression fold change relative to beta actin housekeeping gene in multiple 
time points. *(n = 10, P < 0.05). 
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Figure 20.    TGF-# mRNA expression in WT and KO Periradicular lesions showing 
TGF-# gene expression fold change relative to beta actin housekeeping gene in multiple 
time points. *(n = 10, P < 0.05). 
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Figure 21.    OPG mRNA expression in WT and KO Periradicular lesions showing OPG 
gene expression fold change relative to beta actin housekeeping gene in multiple time 
points. *(n = 10, P < 0.05). 
 
Figure 22.  RANKL mRNA expression in WT and KO Periradicular lesions showing 
RANKL gene expression fold change relative to beta actin housekeeping gene in 
multiple time points. *(n = 10, P < 0.05). 
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Figure 23.    RUNX2 mRNA expression in WT and KO Periradicular lesions showing 
RUNX2 gene expression fold change relative to beta actin housekeeping gene in 
multiple time points. *(n = 10, P < 0.05). 
 
Figure 24.    Alkaline phosphatase (ALP) mRNA expression in WT and KO Periradicular 
lesions showing ALP gene expression fold change relative to beta actin housekeeping 
gene in multiple time points. *(n = 10, P < 0.05). 
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Figure 25.    Buccal view slice showing the amount of bone resorption 
 
 
Figure 26.    Quantification of bone resorption by "CT analysis 
*(n = 5, P < 0.05). 
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Figure 27.    CD73 mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing CD73 gene expression fold change relative 
to beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
 
 
Figure 28.    CD39 mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing CD39 gene expression fold change relative 
to beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
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Figure 29.    IL-1" mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing IL-1" gene expression fold change relative to 
beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
 
 
Figure 30.    IL-6 mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing IL-6 gene expression fold change relative to 
beta actin housekeeping gene. (n = 10). 
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Figure 31.    IL-1" mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing IL-1" gene expression fold change relative to 
beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
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Figure 32.    TGF-" mRNA expression in WT non-exposed, WT PBS-treated and 
NECA-treated mice periradicular lesions showing TGF-" gene expression fold change 
relative to beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
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Figure 33.    RANKL mRNA expression in WT non-exposed, WT PBS-treated and 
NECA-treated mice periradicular lesions showing RANKL gene expression fold change 
relative to beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
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Figure 34.    RUNX2 mRNA expression in WT non-exposed, WT PBS-treated and 
NECA-treated mice periradicular lesions showing RUNX2 gene expression fold change 
relative to beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
 
 
Figure 35.    ALP mRNA expression in WT non-exposed, WT PBS-treated and NECA-
treated mice periradicular lesions showing ALP gene expression fold change relative to 
beta actin housekeeping gene. (n = 10, *P < 0.05 / **P < 0.01). 
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AE!$ -M);20(,$ d!$ &14$ Z!Z!$ 69(4)>2N,$ !"#$ SU(W5&)*1/#2$ .2#3)(-3#$ =UT:W$ +#&#1')+$ +#&+*-'($ 2-6#+,#3'$
1.'"J.8($')$+#,*/.'#$A?@_PT$.32$1[b9$XeC$W(22$/(*,$HFFD!$7&9R#SB$C!$#@QGO@!$
AA!$ XJ&1*,$ Z!P!,$ (0$ &2!,$ D*4.3$ )('#)7/.('$ 1+#&*+()+($ 1+)2*&#$ #0'+.&#//*/.+$ .2#3)(-3#R$ J"-&"$
4)2*/.'#($'"#-+$(#&+#'-)3$)%$;Q5c$.32$)('#)1+)'#,#+-39$5$Z>1($<+1(9$/(*,$HFF@!$7*RHSB$C!$HHQGD@!$
A@!$ %)&'),$ Z!-!$ &14$ /!P!$ U>90),$ KTa$ +#&#1')+($ .($ &#//5(*+%.&#$ =!K$ (#3()+($ -3$ "#./'"$ .32$ 2-(#.(#9$
U&0;9(,$HFF@!$==7RO#FHSB$C!$AHOGDH!$
AO!$ Z9>_1,$/!<!$&14$5!\!$-)>90,$=2#3)(-3#$=UT=W$+#&#1')+($.32$'"#-+$+)/#$-3$2+*,$.22-&'-)39$5$=)&9N$
=)&9N&M>2,$HFFQ!$,9R##SB$C!$#EF?GDF!$
AQ!$ d(**+,$-!,$(0$&2!,$=2#3)(-3#$+#&#1')+$'.+,#'-3,$-3$"#./'"$.32$2-(#.(#9$XeC(90$:C+1$`1J(*0+8$L9;8*,$
HF##!$79R#HSB$C!$#A?#G@F?!$
A?!$ %>9M>',$5!,$(0$&2!,$A0'+.&#//*/.+$3*&/#)'-2#($.&'$'"+)*,"$KTa]$+#&#1')+($')$.&'-6.'#$GL5<.11.:$-3$
)('#)&/.('(9$5$Z>1($<+1(9$/(*,$HFFE!$*&RESB$C!$@EHGA#!$
@F!$ %>9M>',$ 5!,$ (0$ &2!,$ KTFc$ 3*&/#)'-2#$ +#&#1')+($ .&'-6.'#$ GL5<.11.:$ .32$ -3&+#.(#$ (*+6-6./$ )%$
)('#)&/.('(9$5$Z+>2$W)(N,$HFFA!$7<9R#OSB$C!$#@?F?G#A!$
@#!$ /&0)G]>2b*>1,$\!,$(0$&2!,$;:5HA>=R$.3$=[$.2#3)(-3#$+#&#1')+$.,)3-('$1+#6#3'($7)3#$+#()+1'-)3$-3$
+.'($J-'"$.2`*6.3'$-32*&#2$.+'"+-'-(9$W2+1$XeC$/)(;N&0>2,$HFF@!$7=RESB$C!$EFFG@!$
@H!$ %>10+&+1(1,$-!,$.!$/&10&,$&14$`!$\&;0(1*M)2&8(9,$>#//($-3%-/'+.'-3,$"*4.3$1#+-.1-&./$-3%/.44.')+8$
/#(-)3(9$5$:9&2$=&0)>2,$#?Q@!$*;R#FSB$C!$AEEG@!$
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@D!$ L(&82+>,$-!,$(0$&2!,$=2#3)(-3#$,#3#+.'-)3$&.'./8N#2$78$>B[^$.32$>B][$#01+#((#2$)3$+#,*/.')+8$!$
&#//($4#2-.'#($-44*3#$(*11+#((-)39$5$XeC$<(4,$HFFO!$79=R@SB$C!$#HAOG@A!$
@E!$ -M)(+[1(9,$ %!P!,$ (0$ &2!,$ !"#$ .2#3)(-3#$ .T.$ +#&#1')+$ -3"-7-'($ 4.'+-05-32*&#2$ -3%/.44.'-)3$ -3$ .$
3)6#/$%.("-)39$PN$5$/(*C+9$W(22$<>2$Z+>2,$HFF?!$=9RDSB$C!$HA#G?!$
@A!$ /+18,$ -!,$P!.!$X1',$&14$%!$<&)1'(,$?#,*/.')+8$!$ &#//($ %+)4$ ;Q5_Z52#%-&-#3'$4-&#$ %.-/$ ')$ (*11+#(($
&)3'.&'$"81#+(#3(-'-6-'8$+#.&'-)3($2*#$')$/.&<$)%$.2#3)(-3#$1+)2*&'-)39$5$`1J(*0$L(9N&0>2,$HF##!$
*$*ROSB$C!$#E?EGAFH!$
@@!$ %&_&+,$K!,$(0$&2!,$>+)((5+#.&'-6#$.2.1'-6#$-44*3#$+#(1)3(#$')$)+./$&)44#3(./$7.&'#+-.$+#(*/'($-3$
.3$ -32*&'-)3$ )%$ +#&#1')+$ .&'-6.')+$ )%$ 3*&/#.+$ %.&')+5<.11.:$ /-,.32$ U?=G@QW52#1#32#3'$
1#+-)2)3'./$7)3#$+#()+1'-)3$-3$.$4)*(#$4)2#/9$:9&2$<+M9>[+>2$`NN;1>2,$HFFO!$77RDSB$C!$HFQG#A!$
@O!$ Z&20>,$ %!,$ (0$ &2!,$ O*.3'-%-&.'-)3$ )%$ 1#+-.1-&./$ 7)3#$ 2#('+*&'-)3$ -3$ 4-&#$ 78$ 4-&+)5&)41*'#2$
')4),+.1"89$5$L(10$/(*,$HFFF!$#&R#SB$C!$DAGEF!$
@Q!$ 4&$-+2J&,$/!P!,$ (0$ &2!,$!)//5/-<#$ +#&#1')+$T$ <3)&<)*'$4-&#$ (")J#2$ -3&+#.(#2$1#+-.1-&./$ /#(-)3$ (-N#$
.32$)('#)&/.('$3*47#+9$5$X14>4,$HF#H!$$<R@SB$C!$QFDG#D!$
@?!$ 4($:2+J(+9&$/4(,$W!,$(0$&2!,$D-,"#+$#01+#((-)3$)%$,./#&'-35[$.32$,./#&'-35^$-3$1#+-.1-&./$,+.3*/)4.($
'".3$-3$+.2-&*/.+$&8('($.32$.3$-3&+#.(#2$')//5/-<#$+#&#1')+5T$.32$')//5/-<#$+#&#1')+5X$#01+#((-)3$.+#$
.(()&-.'#2$J-'"$+#.&'-6.'-)3$)%$1#+-.1-&./$-3%/.44.'-)39$5$X14>4,$HF#E!$=9RHSB$C!$#??GHFD!$
OF!$ L(*&+,$ -!c!,$ (0$ &2!,$ !)//5/-<#$ +#&#1')+$ T$ #01+#((-)3$ -3$ +#%+.&')+8$ 1#+-.1-&./$ /#(-)3(9$ `10$ X14>4$ 5,$
HF##!$==R#FSB$C!$?FOG#@!$
O#!$ f);,$g!,$=$ +#6-#J$)%$3)6#/$7.&'#+-./$ &)41/#0$ /-1-2(I$ -41/-&.'-)3($ %)+$ '"#$1.'"),#3#(-($)%$.1-&./$
1#+-)2)3'-'-(9$`9&1$X14>4$5,$HF#F!$;RESB$C!$#E#G@!$
OH!$ Z&+',$ 5!X!,$ (0$ &2!,$ Q-1)'#-&")-&$ .&-2$ 1.+'-.//8$ &)3'+-7*'#($ ')$ '"#$ -3%/.44.')+8$ +#(1)3(#($ ')$
A3'#+)&)&&*($%.#&./-(9$5$X14>4,$HFFQ!$$=RQSB$C!$?OAGQH!$
OD!$ V&18,$ .!,$ (0$ &2!,$HB5T$ -($ +#M*-+#2$ %)+$ 2-(*/%-2#$ DHS:_52#1#32#3'$ !Q?X$ (-,3./-3,9$ 5$ XeC$<(4,$
HF#A!$7*7R#SB$C!$AG#E!$
OE!$ K*&+,$-!V!,$(0$&2!,$B=HK$4)/#&*/#$E_ZZ=^$.&'($.($.$4)/#&*/.+$1.''#+3$ ')$#3".3&#$ -3%/.44.'-)3$
2*+-3,$-3%/*#3N.$=$6-+*($-3%#&'-)3I$+)/#$)%$BBaT_5!?;L5!Q?X5H8Bbb$1.'"J.89$=\>-$=&0)>8,$HF#E!$
*9R#SB$C!$(#FFDQEQ!$
OA!$ W;1)&,$W!,$(0$&2!,$B=HK$(-,3./-3,$ -3$ %*3,./$ -3%#&'-)3($.32$2-(#.(#(9$69>10$ `NN;1>2,$HF#H!$$B$C!$
HQ@!$
O@!$ =+*(0*'3,$ L!-!,$ !"#$ +)/#$ )%$ 3*&/#.+$ 4.&+)4)/#&*/#($ -3$ -33.'#$ -44*3-'89$ =9>M$ PN$ K)>9&M$ ->M,$
HFFO!$=RDSB$C!$HAQG@H!$
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OO!$ .(+2,$<!$&14$]!d!$\&14,$B.3,#+$(-,3./($5$2.4.,#25(#/%$+#&),3-'-)3$.&+)(($'"#$'+##$)%$/-%#9$69>10$
=2&10$-M+,$HF#E!$;B$C!$AOQ!$
OQ!$ <(4+1&GW&*0(22&1>*,$X!,$(0$&2!,$A0'+.&#//*/.+$=!K$.&'-6.'#($H=K@$.32$?CE$(-,3./-3,$2*+-3,$-3`*+8$
+#(1)3(#$-3$'"#$%*3,*($!+-&")2#+4.$.'+)6-+-2#9$69>10$=2&10$-M+,$HF#E!$;B$C!$@A?!$
O?!$ 5>)1*>1,$\!,$(0$&2!,$K)+1"8+)4)3.($,-3,-6./-($.''#3*.'#($=!K54#2-.'#2$-3%/.44.()4#$.&'-6.'-)3$
.32$ DHS:_$ +#/#.(#$ '"+)*,"$ #01+#((-)3$ )%$ .$ 3*&/#)(-2#52-1")(1".'#$ <-3.(#9$ <+M9>[(*$ `1b(M0,$
HF#A!$*#RASB$C!$D@?GOO!$
QF!$ -C+249(T>94(,$<!,$ (0$ &2!,$ A0'+.&#//*/.+$ .2#3)(-3#$ V\5'+-1")(1".'#$ .32$ /-1)1)/8(.&&".+-2#$ -32*&#$
-3'#+/#*<-35_7#'.$+#/#.(#$ -3$&.3-3#$7/))29$c(0$ `NN;1>2$ `NN;1>C&0)>2,$HF#E!$*;#R#GHSB$C!$#FAG
#F!$
Q#!$ P7;N&,$<!<!,$ (0$ &2!,$!"#$ +)/#$)%$ ;Q5c$)3$.1-&./$ 1#+-)2)3'-'-(I$ .$ (8('#4.'-&$ +#6-#J9$ `10$ X14>4$ 5,$
HF#E!$=#ROSB$C!$@#AGH#!$
QH!$ .(91&4+,$%!,$(0$&2!,$A/#6.'#2$'*4)+$3#&+)(-($%.&')+5./1".$#01+#((-)3$-3$1#+-.1-&./$/#(-)3($-3%#&'#2$
78$A1('#-35:.++$6-+*(9$5$X14>4,$HF#D!$$&RESB$C!$EA@G@F!$
QD!$ 4($ Z9+0>,$ \!W!,$ (0$ &2!,$ !5/841")&8'#$ .32$ &8')<-3#$ #01+#((-)3$ -3$ "*4.3$ -3%/.44.')+8$ 1#+-.1-&./$
/#(-)3(9$5$X14>4,$HF#H!$$<RESB$C!$EQ#GA!$
QE!$ 6&1,$ /!,$ (0$ &2!,$ ?#&#1')+$ .&'-6.')+$ )%$ 3*&/#.+$ %.&')+$ <.11.$ :$ /-,.32$ .32$ )('#)1+)'#,#+-3$
#01+#((-)3$-3$&"+)3-&$.1-&./$1#+-)2)3'-'-(I$1)((-7/#$.(()&-.'-)3$J-'"$-3%/.44.')+8$&#//(9$W)+1$<(4$
5$RX182S,$HF##!$*7=R#ESB$C!$H#@HG@!$
QA!$ K(+e(+9&G-&2;N,$ K!Z!,$ (0$ &2!,$B-('-3&'$ !"_R$ !"T$ .32$ !+#,$ &8')<-3#($ 7./.3&#$ -3$ &"+)3-&$ 1#+-.1-&./$
,+.3*/)4.($.32$+.2-&*/.+$&8('(9$5$:9&2$=&0)>2$<(4,$HF#F!$$&RDSB$C!$HAFG@!$
Q@!$ `)&1$.9(1,$U!,$(0$&2!,$ ;44*3#$ +#(1)3(#$ -3$ &"+)3-&$1#+-.1-&./$1.+)2)3-'-'-(9$ =b2;8(9*$P9M),$HFFF!$
==9RA$-;CC2SB$C!$/Q@GQ!$
QO!$ %&0([7&4(),$U!,$5!$.;CC,$&14$<!$K9>C(,$D-(')/),-&./$1#+-.1-&./$+#1.-+$.%'#+$)7'*+.'-)3$)%$-3%#&'#2$
+))'$&.3./($-3$2),(9$5$X14>4,$#???!$7;RASB$C!$D@EGQ!$
QQ!$ K&1>N&9;$6+2)>,$<!,$<!/!$ \(>1&94>,$&14$\!P!$4&$-+2J&,$A%%#&'$)%$ -++-,.'-3,$()/*'-)3$.32$&./&-*4$
"82+)0-2#$ +))'$ &.3./$ 2+#((-3,$ )3$ '"#$ +#1.-+$ )%$ .1-&./$ .32$ 1#+-.1-&./$ '-((*#($ )%$ '##'"$ J-'"$
1#+-.1-&./$/#(-)39$5$X14>4,$HFFH!$7<RESB$C!$H?AG?!$
Q?!$ c(9&,$ 5!,$(0$&2!,$C3#5$6#+(*($ 'J)56-(-'$#32)2)3'-&$ '+#.'4#3'$)%$ '##'"$J-'"$.1-&./$1#+-)2)3'-'-(I$.$
"-(')7.&'#+-)/),-&$('*289$5$X14>4,$HF#H!$$<RQSB$C!$#FEFGAH!$
?F!$ Z>1>,$ <!/!,$ (0$ &2!,$ >B][$ .32$ >B[^$ #&')3*&/#)'-2.(#($ -3$ !$ &#//$ 2-%%#+#3'-.'-)3I$ :#8)32$
-44*3)(*11+#((-)39$6XZ-$\(00,$HF#A!$
 
 
92 
?#!$ P2&N,$ <!-!,$ (0$ &2!,$ A0'+.&#//*/.+$ .2#3)(-3#$ ,#3#+.'-)3$ -3$ '"#$ +#,*/.'-)3$ )%$ 1+)5-3%/.44.')+8$
+#(1)3(#($.32$1.'"),#3$&)/)3-N.'-)39$Z+>N>2(M;2(*,$HF#A!$;RHSB$C!$OOAG?H!$
?H!$ 6(18,$ \!,$ (0$ &2!,$ d.(&*/.+$ >B[^PAG!KB_$ 2-+#&'/8$ 1+)4)'#($ '*4)+$ &#//$ ,+)J'"$ 78$ (&.6#3,-3,$
#0'+.&#//*/.+$.2#3)(-3#$'+-1")(1".'#9$U(>C2&*+&,$HF##!$*$RDSB$C!$HF@G#@!$
?D!$ %&*GL((2(1,$P!<!,$(0$&2!,$>8')4#,./)6-+*($-3%#&'-)3$-3&+#.(#($'"#$#01+#((-)3$.32$.&'-6-'8$)%$#&')5
=!K.(#$U>B[^W$.32$#&')5V\3*&/#)'-2.(#$U>B][W$)3$#32)'"#/-./$&#//(9$6XZ-$\(00,$HFF#!$=&*R#GHSB$C!$
H#GA!$
?E!$ U+'>2>J&,$ <!,$ (0$ &2!,$ >B[^P.2#3)(-3#$ 1.'"J.8$ -($ -36)/6#2$ -3$ =;BE$ 1+),+#((-)39$ =\>-$ =&0)>8,$
HF##!$#ROSB$C!$(#FFH##F!$
?A!$ -M);2(9,$ =!5!,$ (0$ &2!,$ >BXUYW>B][UYW$ !$ &#//($ .+#$ .(()&-.'#2$ J-'"$ /)J#+$ !5&#//$ .&'-6.'-)3$ .32$ >$
+#.&'-6#$1+)'#-3$ /#6#/($.32$.+#$2#1/#'#2$-3$D;d5_$-3%#&'-)3$+#,.+2/#(($)%$6-+./$(*11+#((-)39$P`L-,$
HF#D!$7#R#FSB$C!$#AEAGAA!$
?@!$ =(9(*,$/!-!,$(0$&2!,$Q)J$#01+#((-)3$)%$>B[^$)3$+#,*/.')+8$!$&#//($.($.$7-)4.+<#+$%)+$+#(-('.3&#$')$
4#'")'+#0.'#$'"#+.18$-3$+"#*4.')-2$.+'"+-'-(9$=9>M$U&02$PM&4$-M+$^$-$P,$HF#A!$**7RQSB$C!$HAF?G#E!$
?O!$ 62(0M)(9,$ 5!<!,$ (0$ &2!,$ >B[^YL)01[Y$ +#,*/.')+8$ !$ >#//($ (*11+#(($ 1.'"),#3-&$ !"_]$ &#//($ .32$ .+#$
-41.-+#2$-3$4*/'-1/#$(&/#+)(-(9$5$`NN;1>2,$HFF?!$*<$R##SB$C!$O@FHG#F!$
?Q!$ /&T&*('&9&1,$U!,$(0$&2!,$:c9,]$4-&#$ +#&)3('-'*'#2$J-'"$:B>T9V$3)35)7#(#$2-.7#'-&$ U:B>T9VGCBW$
('#4$&#//($2)$3)'$2#6#/)1$.*')-44*3#$2-.7#'#(9$W2+1$XeC$`NN;1>2,$HF#D!$*#=R#SB$C!$HOGDO!$
??!$ -&M'0>9,$Z!,$E)2-*45&)*1/#2$"#0)(#$'+.3(1)+'9$%+41(3$`10,$#?Q?!$$,RDSB$C!$DEHGAF!$
#FF!$ .&*+[,$ \!,$ (0$ &2!,$ L*3&'-)3./$ .32$ ")4#)('.'-&$ 2#%#&'($ )%$ +#,*/.')+8$ !$ &#//($ -3$ 1.'-#3'($ J-'"$
&)+)3.+8$.+'#+8$2-(#.(#9$5$`10(91$<(4,$HF#@!$7#&R#SB$C!$@DGOO!$
#F#!$ a+&,$ U!,$ (0$ &2!,$ =&'-6.'#2$ +#,*/.')+8$ !5&#//($ .''#3*.'#$ 48)&.+2-./$ -(&".#4-.P+#1#+%*(-)3$ -3`*+8$
'"+)*,"$.$>B[^52#1#32#3'$4#&".3-(49$W2+1$-M+$R\>14S,$HF#A!$*7<R#FSB$C!$@O?G?D!$
#FH!$ -;1,$ a!,$ (0$ &2!,$ >B[^PAG!KB_$ #01+#((-)3$ 78$ >BXYL)01[Y$ +#,*/.')+8$ !$ &#//($ 1+)4)'#($ "#1.'-&$
4#'.('.'-&$'*4)+$,+)J'"$-3$4-&#9$d&*09>(10(9>2>83,$HF#F!$*$&RDSB$C!$#FDFGEF!$
#FD!$ <(4+(9>,$ P!$ &14$ Z!U!$ W9>1*0(+1,$ =2#3)(-3#$ .32$ 7)3#$ 4#'.7)/-(49$ K9(14*$ X14>M9+1>2$ <(0&[,$
HF#D!$7=R@SB$C!$H?FGDFF!$
#FE!$ %&_&+,$K!,$(0$&2!,$:$.32$!$ /841")&8'#($.+#$'"#$1+-4.+8$()*+&#($)%$?=G@Q$ -3$'"#$7)3#$+#()+1'-6#$
/#(-)3$)%$1#+-)2)3'./$2-(#.(#9$PN$5$=&0)>2,$HFF@!$*,&RDSB$C!$?QOG?Q!$
#FA!$ .&>,$ \!,$ (0$ &2!,$ =$ (4.//$ 4)/#&*/#R$ )2.3.&.'-7R$ -3"-7-'($ -3%/.44.'-)3$ .32$ 7)3#$ /)(($ &.*(#2$ 78$
#32)2)3'-&$2-(#.(#9$`1b(M0$`NN;1,$HF#A!$<$RESB$C!$#HDAGEA!$
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#F@!$ a+>18,$.!,$(0$&2!,$A%%#&'$)%$./#32+)3.'#$)3$./6#)/.+$7)3#$+#()+1'-)3$.32$.3,-),#3#(-($-3$+.'($J-'"$
#01#+-4#3'./$1#+-.1-&./$/#(-)3(9$`10$X14>4$5,$HF#F!$=$R@SB$C!$EQAG?#!$
#FO!$ <&,$5!,$(0$&2!,$?G=$-3'#+%#+#3&#54#2-.'#2$(-/#3&-3,$)%$='1c-$1+#6#3'($7)'"$1#+-.1-&./$7)3#$#+)(-)3$
.32$ -3%/.44.'-)3$ -3$ '"#$ 4)*(#$ 4)2#/$ )%$ #32)2)3'-&$ 2-(#.(#9$ `1b(M0$ `NN;1,$ HF#D!$ <*RESB$ C!$
#FH#GDF!$
#FQ!$ 4($ <>2>1,$ /!-!,$ (0$ &2!,$ E1)3'.3#)*($ )('#)3#&+)(-($ )%$ '"#$ `.J($ -3$ '"#$ 4.0-//.$ )%$ 4-&#$ )3$
.3'-+#()+1'-6#$'+#.'4#3'I$.$3)6#/$CGe$4)*(#$4)2#/9$Z>1(,$HF#E!$,<B$C!$##G?!$
#F?!$ =9(0+,$ L!,$ (0$ &2!,$D-(')+8$ .32$ 1#+(1#&'-6#($ )%$ =T=$ .2#3)(-3#$ +#&#1')+$ .3'.,)3-('($ .($ 1)'#3'-./$
'"#+.1#*'-&$.,#3'(9$<(4$/(*$/(J,$HF#A!$$;RESB$C!$O?FGQEQ!$
##F!$ V;&1,$d!$ &14$d!Z!$ 5>1(*,$!)J.+2($3#0'$ ,#3#+.'-)3$.2#3)(-3#$=UT=W$ +#&#1')+$ .3'.,)3-('(9$ W;99$
<(4$W)(N,$HF#E!$7*RDESB$C!$D?#QGDA!$
###!$ hhh$`UcP\`L$W`KPK`:U$hhh$
##H!$ %+1*(3,$ d!/!,$ (0$ &2!,$ =*')&+-3#$ .2#3)(-3#$ (-,3./-3,$ 1+)4)'#($ +#,*/.')+8$ !$ &#//54#2-.'#2$ +#3./$
1+)'#&'-)39$5$PN$->M$U(C)9>2,$HF#H!$7$R?SB$C!$#AHQGDO!$
##D!$ :)0&,$P!,$(0$&2!,$!"#$2#6#/)14#3'$.32$-44*3)(*11+#((-6#$%*3&'-)3($)%$>BXUYW$>BTVUYW$L)0K[UYW$
+#,*/.')+8$!$&#//($.+#$*32#+$-3%/*#3&#$)%$'"#$.2#3)(-3#5=T=$.2#3)(-3#$+#&#1')+$1.'"J.89$69>10$
`NN;1>2,$HF#H!$$B$C!$#?F!$
##E!$ <+22*,$ 5!.!,$ (0$ &2!,$ =T=$ .2#3)(-3#$ +#&#1')+$ (-,3./-3,$ -3$ /841")&8'#($ .32$ '"#$ &#3'+./$ 3#+6)*($
(8('#4$+#,*/.'#($-3%/.44.'-)3$2*+-3,$#01#+-4#3'./$.*')-44*3#$#3&#1"./)48#/-'-(9$5$`NN;1>2,$
HF#H!$*<<R##SB$C!$AO#DGHH!$
##A!$ /;+,$\!,$A3#+,8$4#'.7)/-(4$-3$'"#$/-6#+9$W>NC9$=)3*+>2,$HF#E!$=R#SB$C!$#OOG?O!$
##@!$ d>9+1+,$ -!,$ (0$ &2!,$?#,*/.'-)3$ )%$ -33.'#$ -44*3-'8$ 78$ #0'+.&#//*/.+$ 3*&/#)'-2#(9$ PN$ 5$ Z2>>4$ /(*,$
HF#D!$$R#SB$C!$#EGHQ!$
##O!$ 5&M>[*>1,$ %!P!$ &14$ W!X!$ <;22(9,$ H#2-&-3./$ &"#4-('+8$ )%$ .2#3)(-3#R$ KTF$ .32$ KTa$ +#&#1')+(9$
U(;9>C)&9N&M>2>83,$HF#A!$
##Q!$ U>90),$/!P!$&14$<!6!$5&9J+*,$KTa$+#&#1')+($.($2+*,$'.+,#'(9$<>2$=)&9N&M>2,$HF#D!$<$RESB$C!$OA?G
@?!$
##?!$ <>9&14+1+,$ P!W!,$ \!X!$ -&J+>,$ &14$ /!$ W>;0+1)>G-+2J&,$ !"#$ +)/#$ )%$ KTa]$ +#&#1')+$ -3$ -3%#&'-)*($
-3%/.44.')+8$2-(#.(#($.32$'"#$-3%/*#3&#$)%$#&')3*&/#)'-2.(#(9$Z+>N(4$5,$HF#E!$$#RESB$C!$#@?GOO!$
#HF!$ %&_&N;9&,$ .!,$ (0$ &2!,$ A0'+.&#//*/.+$ =!K5('-4*/.'#2$ 4.&+)1".,#($ 1+)2*&#$ 4.&+)1".,#$
-3%/.44.')+8$1+)'#-35T$J"-&"$-($-41)+'.3'$%)+$3#*'+)1"-/$4-,+.'-)39$`NN;1>2>83,$HF#H!$*$,RESB$
C!$EEQGAQ!$
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#H#!$ .>18,$-!,$(0$&2!,$B-%%#+#3'-./$+#,*/.'-)3$)%$KTa]$+#&#1')+$.&'-6.'-)3$78$#0'+.&#//*/.+$3-&)'-3.4-2#$
.2#3-3#$ 2-3*&/#)'-2#$ .32$ #&')5=BK5+-7)(8/'+.3(%#+.(#($ -3$ 4*+-3#$ 4.&+)1".,#($ .32$ !$ &#//(9$ 5$
`NN;1>2,$HFF?!$*<$R#SB$C!$AOQG?H!$
#HH!$ :'+T+,$ K!,$ (0$ &2!,$ B-('+-7*'-)3$ )%$ ;.$ .3'-,#35#01+#((-3,$ 3)3/841")-2$ &#//($ -3$ 6.+-)*($ ('.,#($ )%$
-32*&#2$1#+-.1-&./$/#(-)3($-3$+.'$4)/.+(9$5$X14>4,$#??E!$79R#SB$C!$HOGD#!$
#HD!$ P'&N+1(,$P!,$(0$&2!,$ ;44*3)"-(')&"#4-&./$#0.4-3.'-)3$)3$'"#$ /)&./-N.'-)3$)%$4.&+)1".,#($.32$
1/.(4.$&#//($-3$-32*&#2$+.'$1#+-.1-&./$/#(-)3(9$X14>4$L(10$K9&;N&0>2,$#??E!$*9RDSB$C!$#H#GQ!$
#HE!$ .;&18,$d!K!,$(0$&2!,$A%%#&'$)%$ -3'#+/#*<-35c$2#%-&-#3&8$)3$'"#$%)+4.'-)3$)%$1#+-.1-&./$ /#(-)3($.%'#+$
1*/1$#01)(*+#$-3$4-&#9$:9&2$-;98$:9&2$<(4$:9&2$=&0)>2$:9&2$/&4+>2$X14>4,$HFF#!$&7R#SB$C!$QDGQ!$
#HA!$ Z>9*(22+1>,$ d!,$ (0$ &2!,$ A01+#((-)3$ )%$ #&')3*&/#)'-2.(#$ >B[^$ 78$ L)01[Y$ !+#,$ &#//(I$ "82+)/8(-($ )%$
#0'+.&#//*/.+$=!K$.32$-44*3#$(*11+#((-)39$Z2>>4,$HFFO!$**9RESB$C!$#HHAGDH!$
#H@!$ P2&N,$ <!-!,$ (0$ &2!,$ >B][$ -($ #01+#((#2$ 78$ "*4.3$ +#,*/.')+8$ !$ "#/1#+$ &#//($ .32$ (*11+#((#($
1+)-3%/.44.')+8$&8')<-3#$1+)2*&'-)3$.32$D#/-&)7.&'#+$%#/-(5-32*&#2$,.('+-'-($-3$4-&#9$5$`1b(M0$L+*,$
HFF?!$*&&RESB$C!$E?EGAFE!$
#HO!$ /37)>J,$ -!,$ (0$ &2!,$ A%%#&'$ )%$ =T:$ .2#3)(-3#$ +#&#1')+$ ,#3#$ .7/.'-)3$ )3$ .2#3)(-3#52#1#32#3'$
+#,*/.'-)3$)%$1+)-3%/.44.')+8$&8')<-3#(9$5$=)&9N&M>2$XeC$K)(9,$HFFQ!$$7=RHSB$C!$@?EGOFF!$
#HQ!$ /(8&0(+9>,$6!-!,$(0$&2!,$S#3#+.'-)3$)%$.3'-5-3%/.44.')+8$.2#3)(-3#$78$ /#*<)&8'#($ -($+#,*/.'#2$78$
!SL57#'.9$X;9$5$`NN;1>2,$HF##!$=*R#FSB$C!$H?AAG@A!$
#H?!$ \;M'C9>N,$ =!,$ (0$ &2!,$ =2#3)(-3#$ '+-1")(1".'#$ ('-4*/.'#($ ?=G@Q$ #01+#((-)3$ '"+)*,"$ KTF_$
+#&#1')+5&8&/)5)08,#3.(#52#1#32#3'$ 1.'"J.8$ -3$ "*4.3$ 1#+-)2)3'./$ /-,.4#3'$ &#//(9$ 5$
=(9+>4>10&2$/(*,$HF#F!$=;RDSB$C!$EFEG##!$
#DF!$ Z;M'2(3,$ %!P!,$ (0$ &2!,$ =2#3)(-3#$ '+-1")(1".'#$ ('-4*/.'#($ "*4.3$ )('#)&/.('$ .&'-6-'8$ 6-.$
*1+#,*/.'-)3$)%$)('#)7/.('5#01+#((#2$+#&#1')+$.&'-6.')+$)%$3*&/#.+$%.&')+5<.11.$:$/-,.329$Z>1(,$
HFFH!$$*RASB$C!$AQHG?F!$
#D#!$ \+N,$5!W!$&14$W!.!$<+0M)(22,$;3%/.44.'-)3R$1.-3R$.32$1+#((*+#551*+-3#+,-&$(-,3./-3,$-3$)+./$'-((*#(9$
5$L(10$/(*,$HF#H!$&*R#HSB$C!$##FDG?!$
#DH!$ K&'(4&M)+,$ <!,$ (0$ &2!,$ >B][5,#3#+.'#2$ .2#3)(-3#$ 1+)4)'#($ )('#)7/.('$ 2-%%#+#3'-.'-)39$ 5$ W(22$
=)3*+>2,$HF#H!$77#R@SB$C!$H@HHGD#!$
#DD!$ XJ&1*,$ Z!P!,$B)#($ .2#3)(-3#$ 1/.8$ .$ +)/#$ -3$ 7)3#$ %)+4.'-)3R$ +#()+1'-)3$ .32$ +#1.-+f$ =;9+1(98+M$
-+81&2,$HF#H!$<RHSB$C!$#OOGQF!$
#DE!$ :99+**,$ `!/!,$ (0$ &2!,$ C('#)7/.('$ +#(1)3(#($ ')$ 3*&/#)'-2#($ -3&+#.(#$ 2*+-3,$ 2-%%#+#3'-.'-)39$ Z>1(,$
HFF@!$$&RHSB$C!$DFFG?!$
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